Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005322	s-ige	kU/l (u/ml)	25762	33614	0.01%
3005322	p-ige	kU/l (u/ml)	4231	5482	0.38%
3005322	s-ige	— (—)	2496	2817	100.00%	Distribution not available
3005322	s-ige	kU/l______ (u/ml)	483	569	0.00%
3005322	p-ige	— (—)	321	346	100.00%	Distribution not available
3005322	s-immunoglobuliinie	kU/l______ (u/ml)	198	217	0.00%
3005322	s-immunoglobuliinie	kU/l (u/ml)	124	129	0.00%
3005322	immunoglobuliinie	kU/l (u/ml)	14	18	0.00%
3005322	s-immunoglobuliinie	— (—)	10	10	100.00%	Distribution not available
3005322	s-ige	U/L (u/ml)	9	9	0.00%
3005322	s-ige	KU/L (u/ml)	8	8	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

COPD, early/later onset

2351

8473

2.48

319.68

1.5

1.3

321.45

267.68

u/ml

1.32

2213

7811

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3953

20149

2.00

318.34

1.5

1.3

407.04

193.89

u/ml

7.83

3767

18748

Lower back pain or/and sciatica

6588

24631

1.73

318.30

1.4

1.3

191.55

253.69

u/ml

5.05

6137

22983

General symptoms and signs

6442

19118

1.75

312.65

1.4

1.3

246.01

249.31

u/ml

0.05

5997

17864

Abnormalities of heart beat

2035

8142

2.57

310.78

1.4

1.3

161.01

282.86

u/ml

5.42

1884

7543

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6142

24416

1.75

310.00

1.6

1.3

277.59

230.49

u/ml

1.83

5718

22806

Allergic conjunctivitis

4104

21458

1.96

309.93

1.5

1.3

427.94

194.08

u/ml

7.75

3903

19958

Pruritus

1011

2906

4.03

308.57

1.5

1.3

314.46

130.89

u/ml

5.28

959

2700

Later onset COPD, excluding more controls

950

1503

5.20

307.65

1.4

1.1

292.13

275.02

u/ml

0.17

895

1343

ILD, hospital admissions 1, main diag only

1001

2745

4.18

307.65

1.6

1.3

249.44

244.55

u/ml

0.05

943

2515

Diseases of oesophagus, stomach and duodenum

6553

22457

1.80

307.65

1.4

1.3

193.99

250.92

u/ml

4.32

6145

20960

Non-allergic asthma (mode), excluding more controls

2368

2877

10.29

307.65

1.6

1.1

142.71

188.90

u/ml

1.74

2272

2624

Asthma (only as main-diagnosis), excluding more controls

9926

7763

8.75

307.65

1.6

1.1

301.38

190.81

u/ml

6.32

9548

7125

COPD

2514

5740

3.86

307.65

1.5

1.2

316.43

244.93

u/ml

1.92

2369

5186

Pneumonias (Asthma/COPD co-morbidities)

6339

24497

1.76

307.65

1.6

1.3

275.86

231.35

u/ml

1.73

5906

22874

Asthma, excluding more controls

9749

7763

7.79

307.65

1.6

1.1

308.91

190.81

u/ml

6.80

9350

7125

Urticaria and erythema

3657

12675

3.31

307.65

1.5

1.3

349.91

221.18

u/ml

3.91

3470

11775

Influenza and pneumonia

6673

24454

1.76

307.65

1.6

1.3

273.62

231.11

u/ml

1.65

6222

22821

Other diseases of upper respiratory tract

7503

16859

2.47

307.65

1.5

1.2

274.16

220.88

u/ml

1.67

7046

15593

Conjunctivitis

5296

23560

1.91

307.65

1.5

1.3

385.98

204.48

u/ml

6.93

5010

21906

Other and unspecified dermatitis

4730

15375

3.46

307.65

1.4

1.3

362.37

143.79

u/ml

16.60

4447

14284

Asthma, unspecified (mode), excluding more controls

6313

7216

7.50

307.65

1.5

1.1

261.49

192.92

u/ml

1.85

6031

6622

Asthma (mode)

9760

8076

7.62

307.65

1.6

1.1

309.98

201.06

u/ml

5.75

9356

7408

Deviated nasal septum

1924

7245

2.86

307.65

1.5

1.2

287.37

251.39

u/ml

0.48

1808

6712

Urticaria

3229

10425

3.63

307.65

1.5

1.3

281.12

225.76

u/ml

1.33

3078

9685

Childhood asthma (age<16)

1112

2294

4.23

307.65

1.7

1.1

851.09

194.11

u/ml

6.87

1052

2099

Acute sinusitis

4163

16828

2.44

307.65

1.7

1.3

229.49

219.93

u/ml

0.23

3909

15681

ILD, hospital admissions

1137

3064

4.26

307.65

1.6

1.3

247.03

258.09

u/ml

0.13

1068

2809

COPD/asthma/ILD related infections

6361

16804

1.99

307.65

1.5

1.2

258.27

213.29

u/ml

1.14

5927

15643

Diseases of the skin and subcutaneous tissue

6236

14826

2.22

307.65

1.4

1.3

363.66

137.65

u/ml

14.27

5831

13749

Vasomotor and allergic rhinitis

4293

11036

4.48

307.65

1.6

1.2

437.31

206.40

u/ml

11.30

4123

10199

Acute upper respiratory infections of multiple and unspecified sites

5159

19589

2.03

307.65

1.5

1.3

277.10

223.54

u/ml

1.06

4828

18244

Chronic rhinitis, nasopharyngitis and pharyngitis

3452

8726

4.67

307.65

1.5

1.2

202.76

205.11

u/ml

0.04

3262

8075

ILD medications: immunosuppressive drugs

4103

16697

2.37

307.65

1.5

1.2

398.03

175.82

u/ml

8.32

3862

15449

Other and unspecified effects of external causes

2453

9541

2.89

307.65

1.5

1.3

391.14

221.14

u/ml

3.76

2354

8871

Certain disorders involving the immune mechanism

1528

5296

3.28

307.65

1.8

1.3

223.40

240.89

u/ml

0.18

1358

4948

Other special examinations and investigations of persons without complaint or reported diagnosis

4013

8870

2.42

307.65

1.4

1.2

272.74

260.47

u/ml

0.16

3748

8245

Medical observation and evaluation for suspected diseases and conditions

3758

8869

2.27

307.65

1.4

1.2

258.10

260.50

u/ml

0.02

3522

8244

Chronic sinusitis

4259

11454

4.30

307.65

1.7

1.2

223.42

207.61

u/ml

0.44

4038

10599

Nasal polyp

1734

3873

5.27

307.65

1.8

1.2

393.60

240.49

u/ml

2.67

1686

3588

Atopic dermatitis, strict definition with reimbursement

3221

9909

3.61

307.65

1.6

1.3

959.97

129.67

u/ml

32.13

3085

9201

Examination and observation for other reasons

3690

8838

2.50

307.65

1.4

1.2

213.97

260.94

u/ml

1.32

3472

8216

Asthma, including avohilmo

13193

17563

4.77

307.65

1.5

1.2

290.98

203.05

u/ml

6.83

12533

16130

Interstitial lung disease endpoints

1139

3095

4.21

307.65

1.6

1.3

247.07

257.61

u/ml

0.13

1070

2838

Acute bronchitis

2858

11939

2.53

307.65

1.7

1.3

235.10

247.66

u/ml

0.23

2669

11081

Asthma/COPD (KELA code 203)

10388

17431

4.57

307.65

1.6

1.2

335.49

191.85

u/ml

11.70

9918

15980

5752

16804

2.11

307.65

1.6

1.2

274.64

213.29

u/ml

2.74

5361

15643

First line medication for Crohn's disease

9056

18403

2.87

307.65

1.6

1.2

345.47

182.30

u/ml

11.95

8561

17029

COPD differential diagnosis

5404

8080

3.62

307.65

1.4

1.1

246.67

200.98

u/ml

1.20

5069

7412

Undetermined asthma, excluding more controls

1779

1988

11.75

307.65

1.7

1.1

234.17

177.98

u/ml

1.16

1706

1803

Episodal and paroxysmal disorders

6610

19485

1.79

307.65

1.4

1.3

222.43

266.00

u/ml

1.39

6162

18148

Inflammatory bowel disease treatment related agents

9978

19733

3.08

307.65

1.6

1.2

337.78

189.41

u/ml

11.73

9460

18257

Pain in joint

3951

10686

2.42

307.65

1.4

1.3

184.52

307.16

u/ml

9.98

3703

9947

Sleep apnoea, including avohilmo

6463

20475

2.01

307.65

1.4

1.3

202.36

252.81

u/ml

3.12

6064

19081

Allergic asthma (mode), excluding more controls

2969

4587

7.76

307.65

1.9

1.1

539.38

186.13

u/ml

17.74

2867

4195

Bronchiectasis

1041

1016

14.46

307.65

2.1

1.1

247.76

163.72

u/ml

1.34

990

915

Dyspnoea

7490

20784

2.85

307.65

1.4

1.3

199.10

253.11

u/ml

3.77

7065

19331

ILD, hospital admission 2, with pulmonary infections

779

1580

5.75

307.65

1.7

1.2

226.47

221.44

u/ml

0.05

734

1445

COPD (mode)

1554

2905

4.50

307.65

1.4

1.1

318.60

240.00

u/ml

1.47

1449

2628

ILD medications: prednisolone, methylprednisolone, prednisone

9749

18037

3.32

307.65

1.6

1.2

345.90

175.13

u/ml

14.76

9235

16678

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1054

1057

8.35

307.65

1.7

1.2

240.65

303.99

u/ml

0.75

987

983

Pollen allergy

2534

6838

4.57

307.65

1.6

1.3

486.77

196.44

u/ml

7.91

2446

6338

Pain in throat and chest

5399

14118

2.40

307.65

1.4

1.3

176.33

281.82

u/ml

9.69

5055

13107

Other specific joint derangements/joint disorders

4951

16551

1.96

307.65

1.4

1.3

193.17

269.25

u/ml

4.20

4641

15441

7447

18726

2.12

307.65

1.5

1.2

258.79

223.66

u/ml

0.87

6947

17399

Other chronic obstructive pulmonary disease

2346

5485

3.79

307.65

1.5

1.2

321.33

250.63

u/ml

1.73

2208

4951

Early onset COPD, excluding more controls

1359

2484

6.14

307.65

1.6

1.1

336.16

244.72

u/ml

1.47

1277

2271

Chronic lower respiratory diseases

12804

17467

4.40

307.65

1.5

1.2

304.50

191.66

u/ml

10.07

12202

16012

Immunodeficiencies

652

1290

7.12

307.65

2.0

1.3

218.26

208.09

u/ml

0.07

536

1195

Asthma and allergy, excluding more controls

1908

2621

9.36

307.65

1.9

1.1

664.22

160.94

u/ml

18.38

1849

2386

Asthma-related infections

7273

15149

5.61

307.65

1.7

1.2

333.55

200.93

u/ml

7.08

6970

13847

Allergic contact dermatitis

1270

3793

3.92

307.65

1.5

1.3

324.61

126.02

u/ml

10.54

1205

3518

Atopic dermatitis

5398

16658

2.85

307.65

1.5

1.3

662.01

133.88

u/ml

34.40

5108

15535

Gastro-oesophageal reflux disease

4443

19011

2.09

307.65

1.4

1.3

174.64

249.05

u/ml

5.56

4167

17748

Disorders of conjunctiva

5681

24530

1.89

307.65

1.5

1.3

374.94

207.82

u/ml

6.59

5366

22816

Sleep disorders (combined)

6625

19924

1.81

307.65

1.4

1.3

226.78

254.29

u/ml

0.73

6183

18538

Biological medicines for asthma

719

669

51.26

307.65

3.0

1.3

857.57

224.76

u/ml

7.89

711

623

Non-allergic asthma (mode)

2369

2929

10.10

307.65

1.6

1.1

142.66

206.72

u/ml

2.31

2273

2670

Dorsalgia

6039

18305

1.82

307.65

1.4

1.3

199.19

276.69

u/ml

5.75

5630

17052

Cough

4705

9337

5.60

307.65

1.4

1.3

172.86

288.11

u/ml

6.75

4474

8652

Other chronic obstructive pulmonary disease, including avohilmo

2956

10744

2.40

307.65

1.5

1.3

331.59

250.03

u/ml

2.83

2776

9945

Interstitial lung disease

1139

3095

4.21

307.65

1.6

1.3

247.07

257.61

u/ml

0.13

1070

2838

Other respiratory diseases principally affecting the interstitium

1312

3663

4.06

307.65

1.7

1.3

251.08

260.65

u/ml

0.12

1236

3363

Oral corticosteroids

10069

18744

3.51

307.65

1.6

1.2

351.86

182.85

u/ml

15.13

9554

17349

Any reimbursement code in KELA

3976

9846

2.13

307.65

1.4

1.2

286.63

156.70

u/ml

5.14

3742

9149

Headache

4510

18155

2.03

307.65

1.4

1.3

202.60

247.63

u/ml

1.00

4208

16950

Low back pain

4969

17837

1.98

307.65

1.4

1.3

184.54

272.65

u/ml

7.18

4624

16622

Other soft tissue disorders, not elsewhere classified

5996

18409

1.94

307.65

1.4

1.3

211.80

271.00

u/ml

2.25

5619

17125

Atopic dermatitis, strict definition

2953

11255

2.91

307.65

1.6

1.3

1016.58

137.48

u/ml

30.90

2831

10448

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3876

13449

3.04

307.65

1.5

1.2

201.43

224.36

u/ml

0.75

3649

12462

Pneumonia, organism unspecified

5684

22450

1.82

307.65

1.6

1.3

284.92

231.32

u/ml

2.05

5289

20962

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4462

16843

2.48

307.65

1.5

1.3

210.38

248.61

u/ml

1.52

4183

15675

Symptoms and signs involving the circulatory and respiratory systems

7545

14748

2.75

307.65

1.4

1.3

211.95

282.86

u/ml

3.30

7054

13690

Abnormal findings on diagnostic imaging of lung

3308

11143

3.07

307.65

1.6

1.3

231.33

257.41

u/ml

0.68

3115

10314

Haemorrhage from respiratory passages

1809

5584

3.05

307.65

1.5

1.3

219.21

313.22

u/ml

3.32

1683

5156

Dermatitis

5540

18167

3.33

307.65

1.4

1.3

370.63

145.65

u/ml

19.37

5201

16880

Eosinophilic disease (BM)

283

154

33.28

307.65

3.0

1.1

576.16

78.32

u/ml

4.16

274

139

Pain in limb

5180

17982

1.92

307.65

1.4

1.3

201.42

268.98

u/ml

3.93

4864

16730

Sleep apnoea

6091

19867

2.04

307.65

1.4

1.3

217.14

244.25

u/ml

1.02

5728

18515

ILD differential diagnosis

5401

8076

3.62

307.65

1.4

1.1

246.74

201.06

u/ml

1.20

5067

7408

COPD/asthma related infections

6361

16804

1.99

307.65

1.5

1.2

258.27

213.29

u/ml

1.14

5927

15643

Diseases of the respiratory system

3947

6419

3.29

307.65

1.4

1.1

243.05

184.45

u/ml

1.42

3682

5883

Asthma, hospital admissions 3, pneumonia

3719

7631

5.72

307.65

1.8

1.2

310.76

214.20

u/ml

4.54

3565

6932

Other acute lower respiratory infections

3750

16424

2.33

307.65

1.6

1.3

285.64

251.55

u/ml

0.79

3499

15262

Dermatitis and eczema

9555

21417

2.89

307.65

1.4

1.3

443.85

144.60

u/ml

33.44

8976

19910

Asthma (diagnoses ohter than nonallergic)

10908

20652

5.07

307.65

1.6

1.2

327.88

200.74

u/ml

10.56

10474

18978

Allergic asthma (mode)

2970

4615

7.71

307.65

1.9

1.1

539.24

196.94

u/ml

16.22

2868

4224

Asthma (only as main-diagnosis)

10066

8027

8.63

307.65

1.6

1.1

300.38

200.33

u/ml

5.22

9677

7363

Excluding asthma or asthma-COPD overlap

5439

8105

3.63

307.65

1.4

1.1

245.99

201.51

u/ml

1.17

5098

7435

Asthma and allergy

1909

2531

9.71

307.65

1.9

1.1

663.94

171.19

u/ml

16.76

1850

2303

All pneumoniae

6358

24541

1.76

307.65

1.6

1.3

275.66

231.09

u/ml

1.73

5924

22914

5879

11935

6.01

307.65

1.8

1.2

338.83

202.00

u/ml

5.45

5638

10917

Abnormalities of breathing

7987

14712

3.43

307.65

1.4

1.3

205.62

283.18

u/ml

4.28

7547

13657

Allergic rhinitis

3751

10659

4.17

307.65

1.6

1.3

464.91

183.24

u/ml

12.45

3609

9862

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5752

16804

2.11

307.65

1.6

1.2

274.64

213.29

u/ml

2.74

5361

15643

Asthma-related pneumonia or sepsis

3719

7631

5.72

307.65

1.8

1.2

310.76

214.20

u/ml

4.54

3565

6932

Ethmoidectomy

1469

3591

5.12

307.65

1.9

1.3

251.38

215.94

u/ml

0.57

1413

3360

Childhood asthma (age<16), excluding more controls

1111

2283

4.25

307.65

1.7

1.1

851.89

179.46

u/ml

7.24

1051

2088

Suggestive for eosinophilic asthma

1318

1629

11.55

307.65

2.1

1.2

397.54

217.68

u/ml

2.76

1295

1478

Asthma, hospital admissions , main diagnosis only

10645

20766

5.37

307.65

1.6

1.2

302.74

209.68

u/ml

6.29

10243

19056

Obesity related asthma

4187

8242

6.29

307.65

1.6

1.2

240.76

211.30

u/ml

1.01

4041

7541

FESS (DNB20)

1446

3484

5.23

307.65

1.9

1.3

253.45

216.10

u/ml

0.59

1391

3262

Asthma

9958

8027

7.70

307.65

1.6

1.1

309.19

200.33

u/ml

5.85

9545

7363

Asthma, unspecified (mode)

6400

7465

7.38

307.65

1.5

1.1

260.62

203.37

u/ml

1.39

6114

6847

Adverse effects, not elsewhere classified

2096

6630

3.75

307.65

1.6

1.3

418.92

212.38

u/ml

4.06

2016

6159

Asthma-related pneumonia

3713

7608

5.73

307.65

1.8

1.2

310.94

213.75

u/ml

4.58

3559

6913

COPD, hospital admissions

2341

8404

2.50

307.65

1.5

1.3

321.76

267.69

u/ml

1.33

2205

7744

Undetermined asthma

1779

2007

11.64

307.65

1.7

1.1

234.17

187.23

u/ml

0.88

1706

1827

Acute upper respiratory infections

6902

21476

2.03

307.65

1.5

1.3

267.71

232.81

u/ml

0.78

6451

19985

Bronchitis

7259

23502

1.95

307.65

1.5

1.3

284.73

231.29

u/ml

1.52

6775

21909

Other pulmonary diagnosis

5524

8105

3.69

307.65

1.4

1.1

251.11

201.51

u/ml

1.38

5185

7435

Other interstitial pulmonary diseases

1139

3084

4.22

307.65

1.6

1.3

247.07

255.25

u/ml

0.10

1070

2829

ILD medications

9669

18575

3.07

307.65

1.6

1.2

349.84

176.32

u/ml

14.81

9150

17165

Asthma and opportunity respiratory infection

744

677

17.83

307.65

2.5

1.1

299.47

191.65

u/ml

1.63

722

610

Other and unspecified urticaria

1997

6380

3.68

307.65

1.5

1.3

239.76

229.14

u/ml

0.15

1901

5935

Asthma, hospital admission 2, infections

7273

15149

5.61

307.65

1.7

1.2

333.55

200.93

u/ml

7.08

6970

13847

Migraine

3693

14970

2.04

305.05

1.4

1.3

186.28

231.45

u/ml

0.85

3485

13939

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2141

4208

2.69

304.14

1.3

1.2

230.05

310.82

u/ml

1.07

2000

3881

Dermatographic urticaria

812

2080

4.98

301.24

1.7

1.3

232.61

223.64

u/ml

0.07

776

1935

Other dorsopathies, not elsewhere classified

5990

18377

1.76

296.33

1.4

1.3

199.47

277.43

u/ml

5.90

5597

17120

Voice disturbances

1930

8103

2.62

292.87

1.6

1.3

150.52

233.09

u/ml

3.75

1815

7508

Non-allergic asthma

761

1882

4.81

288.58

1.4

1.3

106.11

132.15

u/ml

1.15

724

1738

Immunodeficiency with predominantly antibody defects

443

725

9.97

285.35

2.0

1.3

74.47

213.66

u/ml

2.90

348

673

Parasetamol

4333

11893

1.92

280.91

1.4

1.3

227.54

289.17

u/ml

2.16

4056

11107

COPD, hospital admissions 1, only main diagnosis

1746

6056

2.64

273.16

1.5

1.3

313.26

258.75

u/ml

1.38

1647

5570

Codeine

5574

17929

1.75

271.20

1.4

1.3

224.12

245.55

u/ml

0.66

5205

16733

Chronic diseases of tonsils and adenoids

4332

15350

1.85

266.19

1.4

1.2

249.70

210.53

u/ml

0.61

4078

14204

Fever of other and unknown origin

3386

15638

1.97

262.57

1.5

1.3

238.01

250.51

u/ml

0.23

3147

14578

ILD, hospital admissions 3, with pneumonia sepsis

623

1410

5.09

261.88

1.7

1.2

206.39

213.06

u/ml

0.07

583

1298

Symptoms and signs involving speech and voice

2152

9951

2.33

258.06

1.5

1.3

163.88

231.77

u/ml

2.96

2022

9219

Other headache syndromes

2723

13701

2.10

256.55

1.4

1.3

183.91

229.46

u/ml

1.07

2551

12759

Chronic laryngitis and laryngotracheitis

955

2955

3.61

256.39

1.6

1.2

193.24

195.98

u/ml

0.04

893

2723

COPD, hospital admission 2, with asthma infections

1618

5608

2.65

254.39

1.6

1.3

329.76

258.85

u/ml

1.37

1523

5164

Early onset COPD

1359

5141

2.89

254.26

1.6

1.3

336.16

262.44

u/ml

1.18

1277

4775

COPD related to multimorbidity

1898

6938

2.45

253.81

1.5

1.3

330.63

260.98

u/ml

1.61

1786

6374

Tramadol

4532

15756

1.80

250.21

1.4

1.3

215.34

246.57

u/ml

1.02

4227

14734

Desensitization to allergens

706

1901

4.80

246.39

1.6

1.3

567.79

246.13

u/ml

2.57

687

1776

Other intervertebral disc disorders

4589

15939

1.78

246.05

1.4

1.3

188.58

268.64

u/ml

5.12

4297

14882

General examination and investigation of persons without complaint and reported diagnosis

3295

8866

2.01

245.96

1.4

1.2

228.10

260.56

u/ml

0.80

3065

8241

Soft tissue disorders

5877

18582

1.68

244.91

1.4

1.3

219.26

271.48

u/ml

1.90

5505

17289

Emphysema

457

833

6.21

244.65

1.5

1.1

231.36

198.76

u/ml

0.46

428

754

Provisional assignment of new diseases of uncertain etiology

3298

17886

1.93

243.40

1.5

1.3

203.55

243.58

u/ml

1.72

3054

16648

Codes for special purposes

3299

17902

1.93

242.92

1.5

1.3

203.49

243.58

u/ml

1.72

3055

16662

Sciatica+with lumbago

3066

14430

1.98

241.57

1.4

1.3

199.21

264.50

u/ml

2.38

2862

13471

Opioids

5734

18267

1.68

240.45

1.4

1.3

232.77

249.87

u/ml

0.45

5354

17039

Codeine or tramadol medication

6456

22368

1.62

238.97

1.4

1.3

222.33

244.49

u/ml

0.79

6018

20871

Neurological diseases

4997

14959

1.74

236.91

1.4

1.3

236.64

270.37

u/ml

0.66

4653

13948

Persons encountering health services for examination and investigation

3347

8870

1.96

233.73

1.3

1.2

268.02

260.47

u/ml

0.08

3140

8245

Asthma mixed form (mode), excluding more controls

396

663

6.92

232.63

1.5

1.1

267.16

171.17

u/ml

1.80

384

606

Dorsopathies

5851

18550

1.65

229.87

1.4

1.3

208.59

278.40

u/ml

4.18

5466

17284

Autoimmune diseases related-to ILD

4923

25375

1.68

227.04

1.4

1.3

211.35

248.67

u/ml

1.61

4610

23663

Other joint disorders

5263

16833

1.69

226.63

1.4

1.3

209.84

269.88

u/ml

2.75

4927

15709

Eosinophilia

284

368

13.50

225.87

3.0

1.2

574.08

270.96

u/ml

1.43

275

346

Asthma mixed form (mode)

396

688

6.66

224.12

1.5

1.1

267.16

174.75

u/ml

1.70

384

630

Other respiratory disorders and diseases

1159

4348

2.88

218.94

1.6

1.3

193.66

255.47

u/ml

1.82

1090

4018

Other diseases of the respiratory system

1159

4348

2.88

218.94

1.6

1.3

193.66

255.47

u/ml

1.82

1090

4018

Oedema, not elsewhere classified

1880

8534

2.28

218.91

1.5

1.3

274.50

241.75

u/ml

0.47

1768

7929

Systemic connective tissue disorders

2115

10365

2.18

217.29

1.5

1.3

175.86

230.81

u/ml

2.06

1962

9600

Other disorders of lacrimal gland

2316

11763

2.10

215.82

1.5

1.3

217.33

216.18

u/ml

0.02

2163

10921

Other diseases of intestines

6239

22553

1.59

215.75

1.4

1.3

188.61

263.96

u/ml

6.74

5837

21040

Spondylosis

2844

11870

1.96

214.82

1.4

1.3

208.98

274.97

u/ml

2.12

2659

11071

Other diseases of pleura

2159

9189

2.14

213.23

1.5

1.3

231.54

280.22

u/ml

1.42

2026

8474

Pain (limb, back, neck, head abdominally)

3830

10931

1.82

211.76

1.3

243.40

308.76

u/ml

1.48

3571

10174

Conjunctivitis (acute, non atopic), including avohilmo

5658

21876

1.61

210.74

1.4

1.3

312.69

213.40

u/ml

3.65

5275

20368

Disorders of lacrimal system

2680

14204

1.96

207.76

1.5

1.3

212.44

220.02

u/ml

0.15

2503

13216

Irritable bowel syndrome

1883

8999

2.25

207.75

1.4

1.3

141.39

233.56

u/ml

5.15

1767

8371

Polypectomy (DHB20)

565

1440

4.68

206.65

2.0

1.3

362.65

231.57

u/ml

1.67

555

1342

Recurrent or chronic depression

2538

9141

2.03

205.35

1.4

1.3

264.84

238.83

u/ml

0.27

2375

8588

Shoulder lesions

3971

14047

1.76

203.23

1.3

170.02

263.18

u/ml

7.95

3733

13090

Neurological diseases, wide definition

1920

4373

2.33

202.06

1.4

1.3

234.94

311.56

u/ml

1.34

1791

4072

Disorders of eyelid, lacrimal system and orbit

4904

22696

1.64

201.35

1.4

1.3

272.83

235.03

u/ml

0.73

4557

21205

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5537

24170

1.60

200.62

1.5

1.3

298.99

225.39

u/ml

2.13

5106

22633

Spondylopathies

3995

14018

1.74

199.56

1.4

1.3

216.92

273.62

u/ml

1.96

3745

13076

Vocal cord dysfunction

984

3115

3.04

196.76

1.5

1.2

126.31

196.58

u/ml

4.41

934

2928

Abdominal and pelvic pain

5389

17247

1.62

195.81

1.4

1.3

210.54

292.52

u/ml

5.24

5046

16053

Symptoms and signs involving the digestive system and abdomen

5396

17253

1.62

195.08

1.4

1.3

204.96

292.46

u/ml

6.29

5048

16058

Lumbar disc prolapse

3502

15152

1.78

194.84

1.4

1.3

174.90

271.19

u/ml

7.49

3275

14141

Neurotic, stress-related and somatoform disorders

5306

23768

1.59

190.46

1.4

1.3

262.37

234.82

u/ml

0.45

4922

22212

Anxiety disorders

5328

23843

1.59

188.36

1.4

1.3

262.45

235.01

u/ml

0.45

4941

22284

Diseases of the musculoskeletal system and connective tissue

3157

8838

1.86

187.32

1.4

1.3

232.63

298.52

u/ml

1.23

2956

8238

Depression or dysthymia

3545

11279

1.78

186.19

1.4

1.3

289.43

246.12

u/ml

0.67

3284

10572

Other systemic involvement of connective tissue (FG)

1561

7084

2.31

185.74

1.4

1.3

165.86

217.06

u/ml

1.70

1435

6567

Anxiety disorders, excluding more controls

4850

19817

1.62

184.53

1.4

1.3

270.80

224.70

u/ml

0.81

4497

18570

Bacterial pneumonia (organism specified)

2219

10501

2.00

183.68

1.7

1.3

270.70

247.99

u/ml

0.36

2065

9693

Dysphagia

1379

6085

2.41

183.27

1.4

1.3

203.52

280.75

u/ml

1.43

1286

5629

Symptoms and signs involving the skin and subcutaneous tissue

4134

24472

1.66

183.05

1.4

1.3

253.20

234.56

u/ml

0.41

3865

22851

COPD, hospital admissions 3, with asthma pneumonia sepsis

1233

4379

2.55

181.64

1.6

1.3

331.00

265.76

u/ml

1.23

1156

4026

Lichen simplex chronicus and prurigo

514

1346

4.47

180.22

1.6

1.3

752.89

154.66

u/ml

4.58

487

1242

Infective dermatitis

754

2512

3.34

179.35

1.5

1.3

689.91

149.72

u/ml

7.76

716

2328

Nerve, nerve root and plexus disorders

5773

23098

1.55

179.34

1.4

1.3

204.32

244.68

u/ml

1.95

5406

21565

Respiratory insufficiency

378

759

5.39

179.14

1.4

1.1

190.89

199.45

u/ml

0.08

350

686

Arthropathies

5179

16905

1.60

178.56

1.4

1.3

211.82

272.11

u/ml

3.17

4844

15776

Myalgia

1564

7382

2.27

177.84

1.5

1.3

242.93

251.63

u/ml

0.05

1471

6857

Diseases of the eye and adnexa

4676

14810

1.64

176.77

1.4

1.3

330.77

210.11

u/ml

3.06

4381

13816

Other antidepressants

5472

18371

1.57

174.07

1.4

1.3

287.90

242.54

u/ml

0.86

5079

17168

Gastrointestinal diseases

3494

10355

1.75

170.75

1.4

1.3

238.90

261.01

u/ml

0.30

3266

9624

Any gastric operation

4578

14557

1.63

170.65

1.4

1.3

225.94

239.59

u/ml

0.28

4257

13585

GASTRO-related operations

4578

14557

1.63

170.65

1.4

1.3

225.94

239.59

u/ml

0.28

4257

13585

Rotator cuff syndrome

3109

12506

1.78

170.18

1.4

1.3

186.97

268.65

u/ml

4.22

2927

11642

Bacterial pneumoniae

2076

9597

1.99

167.45

1.7

1.3

268.68

236.87

u/ml

0.55

1937

8896

Nummular dermatitis

573

1687

3.84

167.40

1.4

1.3

441.43

156.75

u/ml

4.56

540

1553

Mycoses, including avohilmo

5226

26646

1.54

165.84

1.5

1.3

257.19

241.87

u/ml

0.38

4860

24872

Dentofacial anomalies [including malocclusion]

4393

22248

1.61

165.73

1.4

1.3

178.18

239.59

u/ml

3.95

4123

20747

Exposure to unspecified factor

5730

26490

1.52

165.53

1.4

1.3

287.85

235.74

u/ml

1.51

5367

24695

Covid-19 confirmed case

2020

10675

1.99

165.33

1.5

1.3

226.21

251.77

u/ml

0.53

1868

9906

Candidiasis, including avohilmo

1965

10355

2.02

165.05

1.5

1.3

199.96

221.62

u/ml

0.41

1825

9592

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

5627

24467

1.52

162.60

1.4

1.3

220.42

248.57

u/ml

0.66

5273

22805

Pain, not elsewhere classified

1703

8574

2.10

161.76

1.4

1.3

168.10

247.84

u/ml

2.58

1588

7987

Persons encountering health services for specific procedures and health care

6044

24526

1.50

160.30

1.4

1.3

283.18

233.01

u/ml

1.16

5643

22883

Implicit viral Sepsis, including avohilmo

1662

8309

2.11

159.49

1.5

1.3

221.58

234.55

u/ml

0.19

1542

7706

Other systemic involvement of connective tissue

1591

7871

2.15

159.46

1.4

1.3

169.97

219.39

u/ml

1.69

1461

7268

Persons encountering health services in other circumstances, wide

6175

21813

1.49

159.13

1.4

1.3

273.45

240.73

u/ml

0.85

5769

20323

Other and unspecified immunodeficiencies with predominantly antibody defects

222

328

12.02

158.93

2.1

1.2

53.00

280.76

u/ml

2.00

169

305

Follow-up examination after treatment for conditions other than malignant neoplasms

2158

7654

1.95

158.30

1.4

1.2

175.25

254.84

u/ml

4.02

2027

7111

Infections, IBD-co-morbidities

861

2193

2.94

158.17

1.6

1.3

244.08

284.31

u/ml

0.49

788

2045

L04AX Other immunosuppressants

3222

19774

1.70

157.55

1.4

1.3

376.79

220.23

u/ml

3.77

3030

18449

Diagnoses used for exclusion with ILD

1343

6261

2.28

156.43

1.6

1.3

217.72

246.38

u/ml

0.44

1237

5826

Bacterial pneumonia, not elsewhere classified

1934

8947

1.98

155.71

1.7

1.3

274.20

239.79

u/ml

0.57

1808

8287

Simple and mucopurulent chronic bronchitis

282

503

6.45

155.31

1.8

1.2

192.72

204.93

u/ml

0.07

269

457

All influenza

1438

6900

2.21

155.21

1.7

1.3

257.42

254.66

u/ml

0.03

1349

6433

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5968

21796

1.49

154.87

1.4

1.3

250.71

240.76

u/ml

0.24

5615

20310

Sleep disorders

5143

23899

1.53

154.87

1.3

217.18

239.50

u/ml

0.45

4794

22279

Second line medication for Crohn's disease

3306

20501

1.68

154.64

1.4

1.3

369.66

220.30

u/ml

3.63

3108

19116

Intestinal infectious diseases, including avohilmo, including avohilmo

6227

24104

1.48

153.89

1.4

1.3

224.64

253.81

u/ml

0.75

5828

22463

Other arthrosis

2650

10205

1.81

152.93

1.4

1.3

205.50

280.30

u/ml

2.10

2493

9549

Migraine with aura

1720

8908

2.06

151.96

1.4

1.3

156.19

213.42

u/ml

2.32

1636

8277

Other/unspecified dorsalgia

2038

10979

1.92

150.81

1.4

1.3

186.90

262.39

u/ml

3.21

1916

10210

Mycoses

1661

8530

2.07

150.04

1.8

1.3

379.79

246.95

u/ml

2.36

1554

7913

Prurigo nodularis

275

513

7.10

149.73

1.6

1.3

918.75

147.54

u/ml

3.67

265

467

Disorders of synovium and tendon

2918

14889

1.73

149.43

1.4

1.3

177.06

254.64

u/ml

5.14

2756

13862

Insomnia

5073

23939

1.52

149.22

1.3

217.12

241.53

u/ml

0.49

4721

22322

Temporomandibular joint disorders, including avohilmo

3001

17802

1.72

149.08

1.4

1.3

164.55

219.13

u/ml

3.21

2805

16589

Idiopathic urticaria

306

645

6.62

147.89

1.6

1.3

195.68

239.90

u/ml

0.38

297

597

Depression

5340

24524

1.50

146.04

1.4

1.3

274.18

236.26

u/ml

0.68

4937

22959

Other disorders of white blood cells

462

1312

4.18

145.46

2.5

1.3

474.97

214.74

u/ml

2.34

431

1227

Autoimmune diseases excluding thyroid diseases

5624

21002

1.49

144.69

1.4

1.3

265.87

252.49

u/ml

0.30

5268

19602

Other nutritional deficiencies

3943

23587

1.58

144.10

1.4

1.3

259.08

227.12

u/ml

0.73

3720

22004

Personal history of allergy to drugs, medicaments and biological substances

214

337

10.74

143.85

2.2

1.2

208.25

270.58

u/ml

0.32

207

316

Behavioural syndromes associated with physiological disturbances and physical factors

5237

24352

1.50

143.17

1.3

232.97

241.80

u/ml

0.12

4886

22706

Kela reimbursement Agammaglobulinemia (D80-84)

180

240

15.41

142.90

2.3

1.3

73.43

326.01

u/ml

1.42

119

225

Malaise and fatigue

2654

12350

1.75

142.63

1.4

1.3

234.60

247.63

u/ml

0.22

2467

11501

Allergic urticaria

687

2513

3.12

140.78

1.6

1.3

376.79

228.86

u/ml

1.51

653

2334

Autoimmune diseases excluding thyroid diseases, strict definition

5449

20444

1.49

139.48

1.4

1.3

267.87

256.23

u/ml

0.25

5105

19081

Viral Sepsis

1157

5335

2.31

138.80

1.5

1.3

268.23

254.80

u/ml

0.12

1070

4958

Certain infectious and parasitic diseases

5279

18102

1.50

138.12

1.4

1.3

324.32

203.02

u/ml

3.69

4921

16878

Implicit viral Sepsis

1153

5322

2.31

137.96

1.5

1.3

244.01

255.03

u/ml

0.11

1066

4945

Mood [affective] disorders

5568

24930

1.47

137.51

1.4

1.3

268.98

239.05

u/ml

0.53

5133

23332

Mood disorders

5577

24935

1.47

137.43

1.4

1.3

268.73

239.33

u/ml

0.52

5142

23336

Complications of surgical and medical care, not elsewhere classified

5279

24434

1.48

136.60

1.4

1.3

266.09

233.78

u/ml

0.68

4938

22808

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

5007

26998

1.49

134.47

1.4

1.3

317.13

231.02

u/ml

2.25

4643

25213

Enlarged lymph nodes

955

4137

2.48

133.66

1.6

1.3

582.21

260.33

u/ml

1.68

871

3851

D07AA Corticosteroids, weak (group I)

1130

5283

2.33

133.30

1.6

1.3

1459.40

183.30

u/ml

14.78

1076

4933

Functional dyspepsia

1534

7990

2.03

132.45

1.5

1.3

198.89

239.75

u/ml

0.75

1439

7419

Mood disorders, excluding more controls

5032

20367

1.49

132.25

1.4

1.3

278.59

226.83

u/ml

1.01

4644

19075

Care involving use of rehabilitation procedures

3454

20100

1.60

132.16

1.5

1.3

252.86

233.83

u/ml

0.24

3235

18776

Used for control exclusion in common control thyroid runs

5591

19714

1.47

130.94

1.4

1.3

267.65

258.50

u/ml

0.14

5196

18408

Cardiac arrhythmias

3591

14903

1.60

130.22

1.4

1.3

196.15

234.32

u/ml

1.11

3373

13975

Diseases of the ear and mastoid process

6221

22260

1.43

129.85

1.4

1.3

238.12

245.74

u/ml

0.13

5793

20820

Other heart diseases, wide

5128

21606

1.48

128.40

1.4

1.3

222.57

246.78

u/ml

0.69

4813

20218

Polyarthropathies

3407

14015

1.61

128.16

1.4

1.3

235.90

263.03

u/ml

0.63

3165

13113

Finngen Rheumatological endpoints

5198

20552

1.47

127.69

1.4

1.3

218.04

253.39

u/ml

1.27

4850

19235

Other enthesopathies

1663

8992

1.94

127.53

1.4

1.3

191.91

247.61

u/ml

1.66

1558

8385

Bronchitis, not specified as acute or chronic

458

1379

3.62

127.38

1.6

1.1

308.51

206.84

u/ml

1.34

437

1263

Diaphragmatic hernia

1745

9574

1.91

127.37

1.4

1.3

212.96

243.63

u/ml

0.48

1633

8861

211

351

7.49

127.21

2.2

1.2

329.76

161.48

u/ml

2.27

197

321

Cardiovascular diseases

3861

13440

1.58

127.13

1.4

1.3

206.66

256.78

u/ml

1.58

3631

12530

Complications of medical and surgical care

3851

23113

1.54

127.13

1.5

1.3

275.75

229.03

u/ml

0.85

3598

21567

Certain infectious and parasitic diseases, including avohilmo

3699

11969

1.59

126.90

1.4

1.3

270.97

206.94

u/ml

1.50

3443

11148

Disorders of thyroid, IBD co-morbidities

990

2931

2.44

126.41

1.4

1.2

154.35

256.67

u/ml

4.08

940

2746

Cervical disc disorders

1743

9574

1.90

126.35

1.4

1.3

173.18

271.54

u/ml

4.84

1633

8915

Autoimmune diseases

5869

21166

1.44

126.06

1.4

1.3

263.33

251.98

u/ml

0.19

5456

19758

Unspecified chronic bronchitis

226

405

6.34

123.56

1.7

1.1

151.02

204.94

u/ml

0.35

212

367

Persons encountering health services in other circumstances

2322

13794

1.74

123.49

1.4

1.3

275.79

247.05

u/ml

0.29

2147

12819

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

659

2516

2.93

123.27

1.7

1.3

269.50

227.16

u/ml

0.36

624

2335

Migraine without aura

1446

7599

2.04

123.15

1.4

1.3

233.03

207.26

u/ml

0.14

1372

7061

Oxicams

1038

2568

2.40

123.12

1.3

169.29

316.35

u/ml

3.95

968

2380

Migraine, single triptan purchase ok & required. ICD-code if available is included

4430

20657

1.50

121.04

1.4

1.3

189.76

245.66

u/ml

1.43

4173

19238

Triptan medication for migraine, single purchase ok

4430

20657

1.50

121.04

1.4

1.3

189.76

245.66

u/ml

1.43

4173

19238

Anaemias

1441

4713

2.07

120.82

1.5

1.3

352.82

224.15

u/ml

1.07

1344

4447

Continuous positive airway pressure

964

3583

2.37

120.34

1.5

1.3

222.25

260.93

u/ml

0.67

909

3361

Disorders of skin appendages

2943

18796

1.62

119.63

1.4

1.3

239.63

243.03

u/ml

0.06

2766

17493

Coxibs

1307

3302

2.16

119.42

1.3

212.04

351.93

u/ml

3.35

1218

3048

Hypothyroidism, strict autoimmune

3863

16975

1.54

119.41

1.3

196.33

233.73

u/ml

0.69

3578

15819

Depression medications

1851

5083

1.92

119.06

1.3

330.76

250.33

u/ml

0.74

1721

4777

Other symptoms and signs involving the circulatory and respiratory systems

405

1182

3.79

118.95

1.5

1.3

163.34

238.01

u/ml

1.22

377

1094

All anxiety disorders

3746

19543

1.54

118.07

1.4

1.3

290.00

230.94

u/ml

0.81

3470

18325

Unspecified acute lower respiratory infection

913

4096

2.40

118.02

1.8

1.3

375.02

272.86

u/ml

0.89

852

3836

Other complications of surgical and medical care, not elsewhere classified

681

2697

2.80

117.83

1.7

1.3

284.12

239.56

u/ml

0.32

642

2508

Drug-induced adrenocortical insufficiency

240

501

6.72

117.53

2.7

1.3

461.05

208.66

u/ml

0.82

229

469

Antihypertensive medication - note that there are other indications

3768

13056

1.56

117.41

1.4

1.3

229.74

252.58

u/ml

0.44

3515

12185

Childhood allergy (age < 16)

1157

4674

2.22

117.19

1.6

1.3

934.44

178.95

u/ml

7.40

1098

4286

Concussion

2689

13028

1.65

116.30

1.4

1.3

225.91

272.05

u/ml

1.05

2500

12166

Obesity and other hyperalimentation

3636

23086

1.53

115.28

1.4

1.3

248.24

226.88

u/ml

0.43

3433

21543

Symptoms and signs involving the nervous and musculoskeletal systems

2999

19467

1.59

115.17

1.4

1.3

207.02

241.15

u/ml

1.00

2803

18132

Percutaneous Coronary Intervention

3738

15195

1.54

114.83

1.4

1.3

191.00

263.15

u/ml

5.71

3487

14199

Dermatitis due to ingested food

394

1131

4.08

114.68

1.9

1.3

1435.30

177.53

u/ml

5.07

385

1044

Non-invasive ventilation

1354

6064

2.02

114.39

1.6

1.3

179.84

217.15

u/ml

1.18

1249

5702

Nonhereditary hypogammaglobulinemia

172

272

10.14

114.28

2.1

1.2

62.51

308.20

u/ml

1.66

122

254

Cervicobrachial syndrome

1249

6385

2.07

114.00

1.4

1.3

230.97

254.53

u/ml

0.22

1161

5936

Fibromyalgia

686

2774

2.74

113.90

1.5

1.3

131.63

181.40

u/ml

1.18

641

2578

Obesity

3615

23036

1.53

113.42

1.4

1.3

248.74

227.06

u/ml

0.43

3416

21496

Other functional intestinal disorders

2348

13068

1.69

113.20

1.4

1.3

166.67

260.09

u/ml

5.92

2197

12145

Later onset COPD

995

3675

2.26

113.11

1.4

1.3

300.86

266.50

u/ml

0.59

939

3355

Spinal stenosis

2091

9063

1.75

112.69

1.4

1.3

223.91

269.52

u/ml

1.06

1932

8419

Idiopathic pulmonary fibrosis

413

1267

3.59

112.21

1.6

1.3

235.79

259.66

u/ml

0.20

384

1161

Cardiovascular diseases (excluding rheumatic etc)

3908

15150

1.52

112.05

1.4

1.3

210.68

243.97

u/ml

0.91

3677

14164

Anxiety (asthma-related co-morbidities)

3646

18760

1.53

110.78

1.4

1.3

284.88

225.29

u/ml

0.80

3376

17643

Coronary revascularization (ANGIO or CABG)

3720

15203

1.53

110.68

1.4

1.3

190.04

263.03

u/ml

5.82

3471

14207

Diverticular disease of intestine

3258

13279

1.57

110.30

1.3

222.69

259.01

u/ml

0.91

3036

12398

Emergency coronary revascularization (for ACS)

3907

16030

1.51

110.16

1.4

1.3

190.81

261.59

u/ml

5.94

3644

14964

Complications of procedures, not elsewhere classified

4177

23445

1.47

109.16

1.4

1.3

267.67

229.67

u/ml

0.67

3902

21884

Hypothyroidism (congenital or acquired)

1591

4825

1.93

108.09

1.4

1.3

230.09

235.04

u/ml

0.03

1481

4542

Somatoform disorder

1034

5068

2.19

107.46

1.5

1.3

168.55

186.83

u/ml

0.37

960

4724

Hypothyroidism, levothyroxine purchases

1580

4804

1.93

106.88

1.4

1.3

230.73

232.75

u/ml

0.01

1473

4521

Hypothyroidism and >3 levothyroxin purchases

1580

4804

1.93

106.88

1.4

1.3

230.73

232.75

u/ml

0.01

1473

4521

Factors influencing health status and contact with health services

1287

3206

2.08

106.81

1.3

1.2

251.78

301.10

u/ml

0.55

1198

2984

Disorders of the thyroid gland

4887

22659

1.43

106.74

1.4

1.3

180.51

249.77

u/ml

2.47

4546

21169

Other immunodeficiencies

175

303

9.09

106.53

2.4

1.2

287.00

275.39

u/ml

0.03

169

280

Pain in thoracic spine

907

4231

2.29

106.40

1.4

1.3

159.80

235.24

u/ml

1.67

852

3930

Other anxiety disorders

2870

15932

1.59

106.15

1.4

1.3

270.68

226.87

u/ml

0.58

2649

14904

Other disorders of skin and subcutaneous tissue

3598

20720

1.51

105.73

1.4

1.3

259.04

235.06

u/ml

0.61

3348

19324

Other heart diseases

2722

11311

1.62

104.74

1.4

1.3

258.94

249.96

u/ml

0.11

2550

10594

COPD-related respiratory insufficiency

547

2047

2.87

103.79

1.6

1.3

296.15

269.95

u/ml

0.24

523

1888

Arthrosis

3356

12209

1.55

103.75

1.4

1.3

219.56

266.72

u/ml

1.22

3140

11429

ILD medications: azathioprine

802

3600

2.38

103.16

1.4

1.2

178.62

183.27

u/ml

0.06

750

3325

Selective serotonin reuptake inhibitors

4976

18528

1.43

102.55

1.3

306.57

242.85

u/ml

1.17

4618

17320

Soft tissue disorders related to use, overuse and pressure

1362

7408

1.92

102.28

1.4

1.3

278.53

258.23

u/ml

0.17

1274

6866

Ischemic heart diseases

3909

16051

1.49

102.27

1.4

1.3

185.10

264.88

u/ml

6.42

3657

15002

Intestinal infectious diseases

4968

26771

1.41

102.20

1.4

1.3

235.20

244.60

u/ml

0.15

4637

24966

Cervicalgia

1089

5508

2.09

102.14

1.4

1.3

167.04

236.78

u/ml

2.17

1017

5092

Viral pneumonia

729

3159

2.48

102.08

1.7

1.3

257.92

232.88

u/ml

0.19

669

2936

Hypothyroidism, other/unspecified

4574

21451

1.44

101.48

1.4

1.3

182.81

241.63

u/ml

1.72

4255

20015

Disturbances of skin sensation

1648

9550

1.82

101.38

1.4

1.3

229.76

224.72

u/ml

0.05

1558

8909

Dental caries

1242

6182

1.98

101.25

1.5

1.3

260.20

248.27

u/ml

0.14

1147

5808

Implicit Sepsis

3645

18443

1.49

101.07

1.4

1.3

238.49

245.81

u/ml

0.13

3386

17196

Caries of dentine

1113

5468

2.06

101.00

1.5

1.3

261.20

257.19

u/ml

0.04

1030

5132

Adrenocortical insufficiency

335

989

4.09

100.50

2.4

1.3

439.88

203.88

u/ml

1.13

320

916

Implicit fungal Sepsis, including avohilmo

472

1686

3.12

99.84

1.8

1.3

282.22

207.79

u/ml

0.69

432

1571

Hypothyreosis and Thyroxine purchase for inclusion criteria

4746

22385

1.42

99.63

1.4

1.3

183.34

234.79

u/ml

1.48

4419

20882

Other and unspecified drugs and medicaments

591

2381

2.76

99.21

1.7

1.3

276.00

205.59

u/ml

0.85

561

2219

Visual disturbances

2518

16280

1.60

98.98

1.4

1.3

236.50

242.22

u/ml

0.08

2342

15123

Dizziness and giddiness

3775

20425

1.48

98.93

1.4

1.3

197.84

244.50

u/ml

2.06

3505

19071

Disease of hard tissues of teeth, NOS

2435

7931

1.65

98.84

1.3

222.76

250.90

u/ml

0.67

2273

7422

Symptoms and signs involving cognition, perception, emotional state and behaviour

4975

24166

1.41

98.77

1.4

1.3

203.92

245.66

u/ml

1.85

4636

22575

Other symptoms and signs involving the nervous and musculoskeletal systems

2228

14028

1.65

98.45

1.4

1.3

179.87

242.46

u/ml

3.33

2083

13070

Migraine with aura and triptan purchases

1174

6226

2.03

98.31

1.4

1.3

149.08

198.40

u/ml

1.54

1124

5792

ILD-related respiratory insufficiency

244

578

4.97

98.06

1.6

1.3

225.89

231.92

u/ml

0.04

225

534

Implicit bacterial Sepsis, including avohilmo

1973

9931

1.71

97.95

1.5

1.3

298.70

263.94

u/ml

0.50

1828

9217

Hypertensive diseases (excluding secondary)

2900

11051

1.58

97.94

1.4

1.3

234.36

234.24

u/ml

0.00

2733

10363

Dermatitis due to substances taken internally

388

1258

3.49

97.74

1.7

1.3

438.06

137.55

u/ml

3.69

364

1161

Pain and other conditions associated with female genital organs and menstrual cycle

1427

6671

1.90

96.93

1.4

1.3

171.31

226.57

u/ml

1.49

1332

6219

Other arrhythmias

3327

16934

1.51

96.61

1.4

1.3

159.73

242.15

u/ml

6.54

3093

15842

Other inflammation of eyelid, including avohilmo

2612

17140

1.58

96.41

1.4

1.3

260.26

221.69

u/ml

1.14

2452

16000

Triptan medication for migraine, min. 3 purchases

3532

18272

1.50

96.38

1.4

1.3

175.57

211.86

u/ml

0.61

3344

17059

Major coronary heart disease event

3836

15972

1.47

95.62

1.4

1.3

192.36

258.76

u/ml

5.19

3576

14917

Other disorders of urethra and urinary system

3654

17650

1.48

95.24

1.4

1.3

194.12

233.02

u/ml

1.48

3401

16433

Polyarthrosis

972

4322

2.13

95.23

1.4

1.3

154.54

222.19

u/ml

2.77

905

3993

Azathioprine

802

3721

2.30

95.21

1.4

1.2

178.62

183.18

u/ml

0.06

750

3429

Visual disturbances and blindness

2636

17349

1.57

94.79

1.4

1.3

236.81

239.69

u/ml

0.04

2452

16136

Aspergillosis, including avohilmo

129

182

10.86

94.06

4.9

1.3

1213.37

291.04

u/ml

2.19

123

169

Intracranial trauma

2945

13246

1.54

93.79

1.4

1.3

241.44

270.39

u/ml

0.55

2735

12369

Noninfective enteritis and colitis

2458

15984

1.59

93.56

1.5

1.3

233.18

257.78

u/ml

0.47

2292

14895

Selective deficiency of immunoglobulin G [IgG] subclasses

127

183

12.70

93.39

2.0

1.3

88.00

332.19

u/ml

1.01

114

176

Aspergillosis

127

178

11.03

93.24

4.9

1.3

1233.23

296.55

u/ml

2.19

121

165

Other general symptoms and signs

429

1503

3.21

93.19

1.7

1.3

132.86

271.41

u/ml

1.65

414

1409

Other noninfective gastroenteritis and colitis

1351

7557

1.88

93.17

1.6

1.3

266.18

239.50

u/ml

0.35

1252

7021

Other bacterial diseases, including avohilmo

5185

23866

1.39

93.06

1.5

1.3

405.85

207.64

u/ml

7.13

4818

22315

Constipation

4427

21650

1.42

92.01

1.4

1.3

176.86

251.60

u/ml

5.82

4100

20246

L04AA Selective immunosuppressants

1267

7001

1.92

91.98

1.5

1.3

457.62

237.49

u/ml

1.76

1186

6532

Other disorders of adrenal gland

381

1282

3.47

91.70

2.3

1.3

403.07

212.65

u/ml

1.00

365

1186

Disorders of other endocrine glands

2351

14985

1.60

91.61

1.6

1.3

247.27

230.46

u/ml

0.16

2198

13919

Internal derangement of knee

1826

11008

1.70

91.53

1.4

1.3

222.63

273.74

u/ml

1.07

1720

10286

Rheumatism, unspecified

740

3384

2.35

91.49

1.4

1.3

119.30

187.53

u/ml

3.53

692

3120

Heart failure, not strict

3266

15023

1.50

90.90

1.4

1.3

298.31

239.67

u/ml

1.64

3044

14002

Osteopathies and chondropathies

2774

16984

1.54

90.73

1.5

1.3

273.95

230.03

u/ml

0.56

2603

15794

Obesity due to excess calories

2688

17997

1.55

90.39

1.4

1.3

262.08

227.39

u/ml

0.62

2541

16795

Diarrhoea and gastroenteritis of presumed infectious origin

3700

23406

1.45

89.59

1.4

1.3

230.11

247.92

u/ml

0.24

3460

21803

Implicit bacterial Sepsis

1736

8932

1.72

89.42

1.5

1.3

300.74

273.32

u/ml

0.32

1601

8276

Carpal tunnel syndrome

3023

17920

1.50

88.30

1.3

193.25

234.99

u/ml

1.47

2833

16725

Acetic acid derivatives and related substances

1184

3174

1.99

88.18

1.3

196.82

337.73

u/ml

3.67

1098

2930

Other external causes of accidental injury

4139

14769

1.44

87.69

1.4

1.3

278.58

226.38

u/ml

0.82

3879

13730

Endocrine, nutritional and metabolic diseases

4323

15690

1.42

87.13

1.4

1.3

266.76

248.52

u/ml

0.21

4030

14665

Pulmonary eosinophilia, not elsewhere classified

142

240

8.21

86.42

2.7

1.3

357.47

292.35

u/ml

0.26

135

222

Other diseases of blood and blood-forming organs, wide

1123

6089

1.95

86.11

1.8

1.3

303.39

241.47

u/ml

0.76

1017

5669

Gonarthrosis

2823

10673

1.53

84.64

1.4

1.3

208.06

267.42

u/ml

1.51

2635

9985

Other diseases of hard tissues of teeth

2420

8076

1.59

84.51

1.3

218.57

250.13

u/ml

0.80

2235

7555

Dyshidrosis [pompholyx]

186

409

5.94

84.45

1.3

1.2

298.99

156.98

u/ml

1.77

177

378

Sarcoidosis

738

3490

2.28

84.34

1.4

1.3

163.18

225.70

u/ml

0.89

688

3255

Inflammatory diseases of female pelvic organs

3663

17848

1.45

84.22

1.4

1.3

225.38

183.08

u/ml

0.56

3412

16614

Enthesopathies of lower limb, excluding foot

1202

6697

1.88

84.00

1.4

1.3

169.76

269.74

u/ml

3.00

1133

6228

Injuries to the ankle and foot

4013

24897

1.41

83.91

1.4

1.3

249.87

239.43

u/ml

0.14

3769

23242

Exposure to other specified factors

4282

26975

1.40

83.82

1.4

1.3

250.83

243.62

u/ml

0.14

4032

25144

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2923

19782

1.49

82.87

1.5

1.3

281.18

225.51

u/ml

0.78

2721

18441

Hard cardiovascular diseases

3935

16686

1.43

82.77

1.4

1.3

196.47

257.98

u/ml

4.07

3677

15612

Covid-19 suspected case

1322

7636

1.83

82.74

1.4

1.3

163.56

234.00

u/ml

2.41

1229

7117

Implicit Sepsis, including avohilmo

3979

20546

1.41

82.70

1.4

1.3

228.63

241.56

u/ml

0.28

3700

19190

Bacterial Sepsis

1988

10389

1.63

82.68

1.5

1.3

296.97

266.18

u/ml

0.43

1829

9641

Migraine without aura and triptan purchases

1172

6566

1.91

82.34

1.4

1.3

252.20

202.30

u/ml

0.24

1112

6121

Seborrhoeic dermatitis

523

2152

2.62

82.33

1.4

1.3

185.94

156.68

u/ml

0.45

482

1989

Haemorrhoids and perianal venous thrombosis

1541

9162

1.73

82.32

1.3

216.10

257.95

u/ml

0.82

1426

8494

Diseases of middle ear and mastoid

3190

18238

1.47

82.26

1.5

1.3

270.02

242.61

u/ml

0.32

2989

16987

Infections of the skin and subcutaneous tissue

3044

20875

1.48

82.22

1.5

1.3

436.39

232.90

u/ml

6.21

2860

19457

Special screening examination for infectious and parasitic diseases

1317

5433

1.84

82.02

1.4

1.2

184.72

243.74

u/ml

1.75

1209

5060

Accidents

4098

14769

1.42

81.99

1.4

1.3

276.47

226.38

u/ml

0.77

3838

13730

Other diseases of lip and oral mucosa

2185

14291

1.59

81.92

1.4

1.3

212.10

239.82

u/ml

0.55

2036

13303

Mouth breathing

1926

12240

1.63

81.39

1.4

1.3

232.85

265.35

u/ml

0.58

1819

11448

Nausea and vomiting

1313

7366

1.81

81.20

1.5

1.3

198.68

283.91

u/ml

1.76

1226

6805

Meniscus derangement

2441

10689

1.56

80.91

1.4

1.3

192.95

276.76

u/ml

4.23

2271

10004

Other and unspecified rosacea

594

2637

2.47

80.17

1.4

1.3

187.63

186.83

u/ml

0.01

572

2458

Other specified/unspecified arthritis

1317

7641

1.80

79.70

1.4

1.3

226.20

283.02

u/ml

0.77

1234

7113

Deforming dorsopathies

1381

8119

1.77

79.61

1.4

1.3

200.57

269.84

u/ml

1.33

1283

7531

Papulosquamous disorders

1934

12402

1.62

79.06

1.4

1.3

336.10

235.15

u/ml

2.39

1821

11546

Injuries to the knee and lower leg

6080

25318

1.32

78.70

1.4

1.3

221.68

248.28

u/ml

0.97

5710

23574

Conjunctivitis (acute, non atopic)

1565

9525

1.71

78.51

1.5

1.3

371.38

199.69

u/ml

3.39

1464

8869

Congenital malformations of trachea and bronchus

133

236

8.36

78.28

2.1

1.3

89.22

336.86

u/ml

1.32

121

217

Exfoliative dermatitis

119

184

8.65

78.18

2.1

1.2

4369.00

219.66

u/ml

4.72

114

167

Rosacea

793

3972

2.15

78.08

1.4

1.3

186.31

204.41

u/ml

0.25

755

3694

Viral infections characterized by skin and mucous membrane lesions

2159

14224

1.57

77.72

1.6

1.3

484.73

232.57

u/ml

3.72

2001

13238

External causes of morbidity and mortality

3348

11758

1.46

77.70

1.4

1.3

254.39

222.05

u/ml

0.50

3130

10911

Diseases of oral cavity, salivary glands and jaws

2399

8094

1.56

77.70

1.3

215.05

250.03

u/ml

0.86

2228

7571

Hypothyroidism, strict autoimmune, 3 medication purchases required

4260

21130

1.39

77.30

1.3

191.72

229.72

u/ml

0.80

3945

19706

Herpesviral [herpes simplex] infections, including avohilmo

1523

9334

1.71

76.20

1.5

1.3

493.14

200.44

u/ml

2.91

1414

8704

Hypertension, essential

3834

15695

1.41

75.90

1.4

1.3

250.90

222.81

u/ml

0.62

3617

14678

Dental operations

2536

8695

1.53

75.65

1.3

221.67

268.49

u/ml

1.22

2342

8133

Subjective visual disturbances

1343

7982

1.76

75.18

1.4

1.3

194.76

215.10

u/ml

0.39

1245

7391

Artrosis, including avohilmo

3918

15587

1.41

75.16

1.3

218.13

255.76

u/ml

1.03

3671

14597

Syncope and collapse

1950

10496

1.59

74.55

1.4

1.3

237.08

259.09

u/ml

0.40

1814

9760

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2697

18716

1.48

73.68

1.5

1.3

276.95

225.69

u/ml

0.65

2509

17430

Injury, poisoning and certain other consequences of external causes

2750

9403

1.50

73.52

1.3

239.51

216.60

u/ml

0.28

2582

8719

Other arthritis (FG)

1522

9392

1.68

73.03

1.4

1.3

238.39

255.47

u/ml

0.19

1429

8754

Cystitis

4219

18598

1.38

72.89

1.4

1.3

200.06

240.44

u/ml

1.45

3937

17336

Candidiasis

823

4281

2.05

72.37

1.5

1.3

223.46

208.12

u/ml

0.15

768

3977

Infection due to other mycobacteria

146

294

6.17

72.34

2.1

1.2

142.61

289.43

u/ml

0.86

139

276

Atypical mycobacterium lung infection

121

207

7.62

71.89

2.1

1.2

165.99

345.76

u/ml

0.69

115

193

Other reaction to severe stress, and adjustment disorders

2092

13943

1.55

71.77

1.4

1.3

196.69

210.82

u/ml

0.31

1952

13054

Infection due to other mycobacteria, including avohilmo

155

331

5.77

71.72

2.0

1.2

142.04

283.29

u/ml

0.94

148

310

Congenital malformations of the respiratory system, including avohilmo

206

558

4.72

71.50

2.0

1.4

104.97

218.10

u/ml

1.36

193

513

Diseases of salivary glands

1690

10808

1.63

70.32

1.4

1.3

211.18

237.17

u/ml

0.46

1562

10054

Other bacterial diseases

4478

22362

1.35

70.04

1.5

1.3

411.78

214.08

u/ml

6.25

4149

20908

Caries of enamel

4957

24832

1.33

69.79

1.3

230.60

242.48

u/ml

0.28

4591

23210

Hernia of abdominal wall, postoperative

855

4497

1.97

69.60

1.4

1.3

229.67

224.95

u/ml

0.04

801

4197

Impingement syndrome of shoulder

1058

6004

1.84

69.31

1.4

1.3

149.60

249.84

u/ml

6.02

994

5583

Oter anti-inflammatory and antirheumatic agents, non-steroids

796

2156

2.09

69.29

1.3

1.4

184.07

332.91

u/ml

3.14

737

1992

Trochanteric bursitis

730

3690

2.09

68.97

1.3

138.36

199.68

u/ml

2.50

674

3399

Suppurative and unspecified otitis media

2093

12428

1.55

68.86

1.5

1.3

286.91

240.20

u/ml

0.41

1957

11562

Heart failure and antihypertensive medication

1041

3729

1.88

68.80

1.4

1.3

320.80

224.65

u/ml

1.16

970

3454

Gonarthrosis [arthrosis of knee](FG)

3310

13683

1.42

68.57

1.4

1.3

206.35

254.39

u/ml

1.39

3087

12817

Dental pulpitis, including avohilmo

4883

23953

1.33

68.51

1.3

213.71

248.55

u/ml

1.38

4578

22374

Cervicocranial syndrome

577

2683

2.29

68.39

1.4

1.3

141.87

245.78

u/ml

2.06

541

2497

Nonorganic sleeping disorders, excluding more controls

1186

7000

1.78

68.27

1.4

1.3

172.10

189.21

u/ml

0.35

1106

6546

Heartburn

607

2885

2.24

67.98

1.4

1.3

124.62

267.49

u/ml

3.90

576

2675

Other viral diseases, including avohilmo

2185

14725

1.52

67.88

1.5

1.3

262.40

247.88

u/ml

0.17

2032

13751

Psychiatric diseases

4699

17828

1.34

67.63

1.4

1.3

269.95

229.30

u/ml

0.90

4356

16708

Reimbursement for rheumatic diseases

2750

19390

1.45

67.55

1.4

1.3

145.87

237.20

u/ml

9.70

2563

18078

Bullous disorders

339

1251

2.99

67.52

1.5

1.3

654.14

212.28

u/ml

5.44

324

1155

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

4433

22675

1.35

67.27

1.4

1.3

219.82

244.01

u/ml

0.72

4122

21176

Fenamates

662

2157

2.18

66.43

1.4

1.3

152.08

296.68

u/ml

3.44

617

2000

Lung cancer and mesothelioma

485

1753

2.42

66.35

1.3

1.1

268.31

235.57

u/ml

0.32

447

1575

Propionic acid derivatives

1239

3595

1.78

65.94

1.3

1.4

297.77

358.71

u/ml

0.36

1159

3327

Osteoporosis

1101

5876

1.79

65.32

1.5

1.3

229.03

213.43

u/ml

0.23

1017

5376

Benign neoplasm of colon, rectum, anus and anal canal

2607

15519

1.45

64.74

1.4

1.3

226.73

241.36

u/ml

0.24

2404

14458

Nonsuppurative otitis media, including avohilmo

1833

10469

1.57

64.61

1.5

1.3

249.84

243.20

u/ml

0.09

1701

9707

Paracetamol or NSAID medication

777

1953

2.07

64.38

1.3

361.01

394.49

u/ml

0.10

722

1814

Benign neoplasm: Colon

2177

13970

1.50

64.25

1.4

1.3

239.83

242.42

u/ml

0.03

2005

12997

Other contact dermatitis

451

1947

2.50

64.21

1.4

1.3

449.64

132.04

u/ml

3.19

428

1806

Sulfasalazine

1202

7210

1.72

64.06

1.4

1.2

138.38

176.84

u/ml

1.24

1124

6631

Sicca syndrome [Sjögren]

497

2251

2.40

63.89

1.4

1.3

123.10

181.67

u/ml

1.57

450

2080

Hyperkinetic disorders, excluding more controls

899

4663

1.91

63.76

1.4

1.3

247.07

232.68

u/ml

0.15

835

4352

Excessive attrition of teeth

3248

23690

1.39

63.63

1.4

1.3

206.85

242.10

u/ml

1.10

3029

22142

Chronic gastritis

1035

5968

1.79

63.60

1.4

1.3

187.83

250.11

u/ml

1.74

964

5504

Bacterial infection, other or unspecified, including avohilmo

2519

14488

1.46

63.37

1.5

1.3

298.48

218.25

u/ml

2.44

2311

13494

Symptoms and signs concerning food and fluid intake

544

2546

2.26

62.90

1.5

1.3

345.29

269.83

u/ml

0.24

514

2353

Methotrexate

622

3064

2.14

62.87

1.3

1.2

156.36

167.70

u/ml

0.15

577

2805

Congenital malformations of the respiratory system

185

512

4.61

62.38

2.0

1.4

106.14

229.47

u/ml

1.37

173

471

Vasomotor rhinitis (mode)

439

1910

2.51

62.16

1.5

1.3

247.20

195.69

u/ml

0.28

414

1778

Other necrotizing vasculopathies (FG)

312

1148

2.96

62.02

1.5

1.3

163.93

228.82

u/ml

0.98

290

1061

Endometriosis

1788

6791

1.59

61.76

1.4

1.3

149.42

213.33

u/ml

2.45

1658

6320

Other skin changes

922

5207

1.85

61.70

1.4

1.3

277.68

245.30

u/ml

0.26

848

4809

Other diseases of urinary system

4778

20700

1.32

61.51

1.4

1.3

214.75

250.40

u/ml

1.21

4449

19334

Hypothyroidism, drug reimbursement

800

2963

1.98

61.33

1.4

1.3

131.74

210.65

u/ml

4.37

746

2800

Condition for Implicit Sepsis (Organ dysfunction codes)

4027

21145

1.34

61.29

1.4

1.3

230.46

242.79

u/ml

0.26

3747

19751

Falls/tendency to fall

5467

21481

1.30

60.81

1.4

1.3

253.82

243.82

u/ml

0.19

5117

20033

Pemphigoid

179

481

4.27

60.53

1.4

1.2

644.59

177.09

u/ml

5.20

170

438

Injuries to the wrist and hand

5120

26594

1.30

60.53

1.4

1.3

269.79

239.64

u/ml

0.66

4787

24803

Other symptoms and signs involving the digestive system and abdomen

838

4627

1.90

60.47

1.5

1.3

166.72

232.03

u/ml

1.42

787

4266

Other shoulder lesions

522

2453

2.27

60.46

1.4

1.3

182.94

227.77

u/ml

0.71

484

2261

Menorrhagia

1733

6287

1.59

60.37

1.3

140.50

213.20

u/ml

2.99

1624

5861

Excessive, frequent and irregular menstruation

2074

7473

1.53

60.35

1.4

1.3

144.71

225.35

u/ml

5.33

1940

6940

Acute suppurative otitis media

1589

9665

1.60

60.24

1.5

1.3

280.99

248.53

u/ml

0.20

1479

9004

Rheumatoid arthritis

1363

7553

1.65

60.21

1.3

161.62

262.93

u/ml

4.03

1278

7024

Exclusions for E4_PCOS_BROAD

964

5573

1.82

60.10

1.8

1.3

371.02

226.39

u/ml

0.80

907

5214

Hypertension

3849

16320

1.36

60.06

1.4

1.3

248.37

222.63

u/ml

0.56

3616

15267

Other inflammation of eyelid

738

3933

1.98

60.04

1.5

1.3

303.56

236.33

u/ml

0.81

707

3651

Hypertensive diseases

3853

16346

1.36

59.97

1.4

1.3

248.16

222.47

u/ml

0.56

3620

15291

Budesonide

673

3472

2.04

59.84

1.5

1.2

167.06

173.42

u/ml

0.08

627

3191

Any death

1216

13636

0.61

59.73

1.3

466.19

247.44

u/ml

1.68

1098

12675

Occupational exposure to risk-factors

236

773

3.51

59.22

1.5

1.3

203.09

244.81

u/ml

0.25

219

718

Any mental disorder

5269

20671

1.30

59.14

1.4

1.3

290.61

227.10

u/ml

1.40

4875

19363

Heart failure,strict

1905

8923

1.52

58.74

1.4

1.3

327.45

257.73

u/ml

1.39

1779

8244

Abnormal findings on examination of blood, without diagnosis

1926

11839

1.51

58.66

1.4

1.3

301.81

274.50

u/ml

0.26

1815

11026

Pulmonary heart disease, diseases of pulmonary circulation

1262

7850

1.66

58.23

1.5

1.3

212.52

243.89

u/ml

0.58

1179

7245

Gout

920

4486

1.81

57.65

1.4

1.3

412.87

309.20

u/ml

1.22

839

4171

Abnormal results of function studies

495

2329

2.28

57.49

1.4

1.3

144.57

259.57

u/ml

1.98

464

2164

Other gastritis (incl. Duodenitis)

905

5179

1.81

57.42

1.5

1.3

259.56

272.32

u/ml

0.13

837

4794

L04AD Calcineurin inhibitors

625

3220

2.08

57.09

1.5

1.4

616.94

261.96

u/ml

2.21

583

3017

Erysipelas, including avohilmo

3204

17623

1.37

56.71

1.4

1.3

532.14

208.16

u/ml

8.08

2990

16444

Disorders of sclera, cornea, iris and ciliary body

2628

19075

1.41

56.64

1.4

1.3

375.75

224.90

u/ml

2.47

2440

17794

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2283

10069

1.47

56.58

1.4

1.3

159.28

231.25

u/ml

3.41

2147

9433

Nonsuppurative otitis media

1341

7390

1.64

56.56

1.5

1.3

279.42

263.22

u/ml

0.17

1245

6839

Benign neoplasms

4865

20706

1.30

56.25

1.4

1.3

187.53

270.55

u/ml

6.95

4535

19315

Other diseases of anus and rectum

1258

7854

1.64

56.24

1.4

1.3

223.92

263.87

u/ml

0.41

1173

7279

Implicit fungal Sepsis

255

895

3.19

56.21

2.0

1.3

332.43

214.85

u/ml

0.77

233

833

Rash and other nonspecific skin eruption

530

2588

2.19

55.90

1.6

1.3

383.25

210.18

u/ml

1.74

500

2398

Other epidermal thickening

291

1101

2.94

55.62

1.4

1.3

250.96

206.61

u/ml

0.38

279

1021

Other disorders of patella

903

5238

1.81

55.44

1.4

1.3

217.99

266.76

u/ml

0.45

852

4897

Bacterial infection, other or unspecified

2196

13017

1.45

55.23

1.5

1.3

296.93

221.50

u/ml

2.15

2007

12102

Other viral diseases, not elsewhere classified, including avohilmo

1528

10034

1.57

55.21

1.5

1.3

251.57

243.11

u/ml

0.09

1427

9365

Paroxysmal tachycardia

1096

5521

1.71

54.88

1.4

1.3

169.92

255.38

u/ml

2.87

1029

5143

Radiculopathy

658

3465

1.98

54.73

1.4

1.3

144.84

244.21

u/ml

4.32

615

3203

Anti-inflammatory and antirheumatic products, non-steroids

1190

3598

1.71

54.71

1.3

1.4

303.09

358.50

u/ml

0.31

1107

3330

Other necrotizing vasculopathies

365

1543

2.56

54.68

1.5

1.3

194.81

225.11

u/ml

0.28

339

1431

Fungal Sepsis

265

963

3.06

54.65

1.9

1.3

339.45

212.78

u/ml

0.89

242

897

Diseases of the digestive system

1905

13026

1.49

54.65

1.4

1.3

285.96

258.99

u/ml

0.37

1774

12079

Non-selective monoamine reuptake inhibitors

1590

10141

1.55

54.50

1.4

1.3

204.77

220.51

u/ml

0.24

1478

9443

Bleeding

3584

19059

1.34

54.40

1.4

1.3

248.10

260.32

u/ml

0.24

3332

17776

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4897

24429

1.29

53.97

1.4

1.3

210.83

246.40

u/ml

1.32

4556

22841

Tonsillectomy and adenotomy

3250

16983

1.37

53.90

1.4

1.3

253.53

230.47

u/ml

0.25

3062

15893

Spondylolisthesis/Spondylolysis

804

4536

1.85

53.90

1.4

1.3

222.70

239.00

u/ml

0.14

753

4190

Other sleep disorders

554

2776

2.11

53.80

1.5

1.3

378.06

278.61

u/ml

0.23

522

2581

Bullous pemphigoid

140

343

4.71

53.78

1.5

1.2

605.13

173.89

u/ml

4.33

133

314

Herpesviral [herpes simplex] infections

650

3458

2.00

53.60

1.7

1.3

942.93

211.34

u/ml

3.29

600

3220

Disorders of vestibular function (Vertigo)

2034

13891

1.46

53.23

1.4

1.3

161.33

241.49

u/ml

4.47

1892

12906

Lateral epicondylitis

681

3681

1.95

53.02

1.4

1.3

175.72

217.86

u/ml

0.72

644

3424

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1563

10471

1.55

52.70

1.4

1.3

182.90

257.52

u/ml

2.67

1473

9779

Pleural plaque

329

1337

2.59

52.66

1.3

316.88

333.07

u/ml

0.08

306

1212

Other enthesopathy of foot (+metatarsalgia)

551

2790

2.09

52.25

1.3

176.58

195.69

u/ml

0.29

510

2576

All influenza (not pneumonia)

706

3870

1.91

52.22

1.6

1.3

278.44

243.60

u/ml

0.29

654

3606

Other disorders of ear

4264

21511

1.30

51.59

1.4

1.3

196.53

255.47

u/ml

3.40

3951

20131

5-aminosalicylic acid

923

5476

1.75

51.57

1.3

1.2

237.44

180.66

u/ml

0.71

866

5049

Transport accidents

2296

13721

1.42

51.24

1.4

1.3

217.07

225.75

u/ml

0.16

2155

12759

Acute pharyngitis

851

4919

1.79

51.04

1.4

1.3

233.32

249.31

u/ml

0.16

807

4577

Genitourinary diseases

2645

9615

1.41

50.78

1.4

1.3

333.40

300.58

u/ml

0.33

2467

9001

Metabolic disorders

4450

20974

1.29

50.54

1.4

1.3

214.09

244.35

u/ml

1.19

4168

19603

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3365

23470

1.33

50.19

1.4

1.3

206.90

245.22

u/ml

1.00

3144

21922

Dislocation, sprain and strain of joints and ligaments at neck level

892

5317

1.77

50.14

1.4

1.3

202.91

229.09

u/ml

0.34

828

4977

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2147

15211

1.43

49.95

1.4

1.3

287.36

243.33

u/ml

0.40

2007

14191

Other bacterial intestinal infections, including avohilmo

1065

6617

1.67

49.89

1.5

1.3

247.50

238.92

u/ml

0.10

986

6120

Collagenous colitis

502

2508

2.14

49.87

1.6

1.3

225.71

195.21

u/ml

0.31

466

2328

Other and unspecified nerve root and plexus disorders, also in other diseases

996

6105

1.70

49.58

1.5

1.3

184.79

250.88

u/ml

1.13

924

5708

Atrial fibrillation and flutter

1343

5594

1.59

49.40

1.3

276.93

247.23

u/ml

0.30

1262

5232

Missing teeth due to accident, extraction or parodontitis

2610

17218

1.38

49.37

1.4

1.3

281.47

243.17

u/ml

0.47

2389

16072

Irregular menses

2847

16008

1.37

49.19

1.4

1.3

197.38

191.65

u/ml

0.05

2662

14936

Acute generalized exanthematous pustulosis

293

1186

2.75

49.11

1.7

1.3

329.62

204.97

u/ml

0.97

274

1094

Diseases of pulp and periapical tissues and dental caries

2756

10376

1.39

49.00

1.3

255.46

237.62

u/ml

0.20

2542

9711

Dental caries, including avohilmo

3078

11783

1.36

48.62

1.3

252.23

238.45

u/ml

0.16

2847

11037

Superficial injury of lower leg

1339

8833

1.57

48.56

1.4

1.3

218.91

260.02

u/ml

0.66

1262

8178

Obesity, other/unspecified

1790

12513

1.48

48.56

1.4

1.3

218.82

223.05

u/ml

0.05

1695

11685

Generalized skin eruption due to drugs and medicaments

265

1031

2.88

48.34

1.8

1.3

352.49

210.91

u/ml

1.02

248

953

Other and unspecified tonsillitis

1749

10067

1.49

48.21

1.4

1.3

240.87

236.69

u/ml

0.05

1634

9370

Caries of dentine, including avohilmo

3413

13265

1.34

48.11

1.3

258.66

237.60

u/ml

0.30

3161

12414

Psoriasis

1310

8650

1.57

47.22

1.4

1.3

322.78

242.18

u/ml

1.48

1243

8050

Septicaemia

1651

10355

1.49

47.12

1.5

1.3

341.68

233.81

u/ml

2.65

1514

9601

Pneumonia due to other infectious organisms, not elsewhere classified

202

688

3.27

46.88

2.1

1.3

398.65

183.91

u/ml

1.04

184

642

Hypermobility syndrome

396

1873

2.34

46.73

1.6

1.3

141.40

228.59

u/ml

1.00

372

1756

Other diseases of oesophagus

407

1914

2.24

46.71

1.6

1.3

270.51

290.04

u/ml

0.08

385

1761

Polyneuropathies and other disorders of the peripheral nervous system

859

5139

1.73

46.65

1.5

1.3

273.79

262.06

u/ml

0.09

802

4761

Zoster [herpes zoster], including avohilmo

2232

15704

1.40

46.44

1.4

1.3

258.05

224.31

u/ml

0.67

2057

14595

Diseases of pulp and periapical tissues, including avohilmo

4982

20660

1.27

46.41

1.3

260.05

238.13

u/ml

0.41

4599

19292

Diseases of inner ear

2304

16151

1.39

46.39

1.3

160.52

241.11

u/ml

5.37

2143

15023

Unspecified/other endometriosis

598

3185

1.96

46.29

1.4

1.3

137.14

228.74

u/ml

1.92

553

2973

Unspecified privation

545

2873

2.01

46.15

1.6

1.3

332.75

241.70

u/ml

0.96

525

2671

Nonorganic sleeping disorders

1186

7726

1.60

46.01

1.4

1.3

172.10

235.46

u/ml

1.56

1106

7197

Angina pectoris

2010

9466

1.44

45.93

1.4

1.3

201.12

274.01

u/ml

2.56

1860

8782

Coxarthrosis

1874

8473

1.45

45.73

1.3

289.99

263.58

u/ml

0.28

1724

7922

Allergic contact dermatitis due to drugs in contact with skin

173

553

3.67

45.73

1.7

1.3

531.72

223.71

u/ml

1.59

167

514

Benzodiazepine use

4804

26072

1.26

45.68

1.4

1.3

254.77

236.74

u/ml

0.25

4444

24367

Erysipelas

2234

14031

1.40

45.64

1.5

1.3

582.58

221.65

u/ml

6.10

2080

13072

Metatarsalgia

495

2534

2.07

45.56

1.3

164.50

196.82

u/ml

0.56

458

2335

Endometriosis of pelvic peritoneum

897

4970

1.72

45.54

1.4

1.3

124.47

212.67

u/ml

2.98

831

4649

Urinary track infection

3315

12708

1.34

45.39

1.4

1.3

176.96

199.68

u/ml

0.68

3080

11856

Post-traumatic stress disorder

587

3202

1.96

45.33

1.4

1.3

177.49

188.73

u/ml

0.14

540

3004

Xerosis cutis

135

369

4.32

45.22

1.3

1.2

212.74

213.78

u/ml

0.00

129

339

Disturbance of activity and attention

899

5393

1.72

45.12

1.4

1.3

294.47

252.94

u/ml

0.37

836

5030

Diseases of external ear

1614

11207

1.48

45.09

1.5

1.3

356.34

253.92

u/ml

1.18

1495

10423

Gingivitis and periodontal diseases

4587

18879

1.27

45.06

1.3

261.02

240.27

u/ml

0.32

4242

17649

Persons with potential health hazards related to communicable diseases

2093

15096

1.41

45.01

1.5

1.3

226.68

245.98

u/ml

0.36

1965

14088

Other septicaemia, including avohilmo

1482

9466

1.50

44.94

1.5

1.3

377.73

226.87

u/ml

3.12

1364

8769

Congenital malformations, deformations and chromosomal abnormalities

3042

22138

1.33

44.84

1.4

1.3

202.27

246.01

u/ml

1.22

2840

20662

Heart failure, strict

2009

9965

1.43

44.81

1.3

320.79

266.39

u/ml

1.03

1875

9174

Ovarian cyst

1765

7022

1.48

44.81

1.4

1.3

158.88

217.14

u/ml

1.91

1639

6529

Injuries to the neck

1182

7737

1.59

44.66

1.4

1.3

217.26

245.33

u/ml

0.42

1101

7219

Acute laryngitis and tracheitis

690

3887

1.84

44.57

1.6

1.2

286.59

259.92

u/ml

0.23

652

3621

Other viral diseases

1547

10676

1.49

44.22

1.5

1.3

280.79

255.85

u/ml

0.24

1436

9967

Polyarteritis nodosa and related conditions

120

308

4.72

44.21

2.3

1.2

262.75

292.61

u/ml

0.10

114

285

DVT of lower extremities and pulmonary embolism

1589

10969

1.48

44.21

1.5

1.3

204.36

242.70

u/ml

0.93

1486

10143

Use of hypnotics and sedatives

4958

22886

1.26

44.10

1.4

1.3

237.84

236.50

u/ml

0.02

4611

21421

Atrial fibrillation and flutter with reimbursement

1004

3911

1.67

44.06

1.3

248.33

255.04

u/ml

0.06

945

3638

Pulmonary embolism

1124

7271

1.59

44.02

1.5

1.3

205.02

244.61

u/ml

0.74

1047

6715

Fall on same level

5697

24867

1.24

44.01

1.4

1.3

250.25

242.22

u/ml

0.17

5336

23198

1394

8457

1.52

43.89

1.3

232.16

249.71

u/ml

0.22

1287

7772

Other septicaemia

1437

9212

1.50

43.83

1.5

1.3

360.30

226.08

u/ml

3.23

1322

8529

Psoriasis vulgaris

856

5215

1.71

43.77

1.4

1.3

315.01

245.13

u/ml

0.87

813

4864

Other and unspecified iron deficiency

1478

10121

1.50

43.77

1.5

1.3

317.09

224.14

u/ml

0.76

1371

9365

Explicit Sepsis

1782

11486

1.44

43.70

1.5

1.3

336.09

265.86

u/ml

1.21

1637

10666

Explicit Sepsis, including avohilmo

1828

11780

1.44

43.67

1.5

1.3

350.84

266.51

u/ml

1.38

1681

10939

Common variable immunodeficiency

145

7.61

43.54

2.2

1.2

93.49

333.44

u/ml

0.77

134

Chronic apical periodontitis

5357

24490

1.24

43.54

1.3

270.12

234.53

u/ml

0.75

4952

22885

Dermatophytosis, including avohilmo

3063

23145

1.32

43.52

1.4

1.3

259.48

245.83

u/ml

0.25

2843

21603

Generalized anxiety disorder

982

6205

1.65

43.43

1.4

1.3

335.58

210.77

u/ml

0.73

918

5777

Pulmonary heart disease

1124

7297

1.58

43.34

1.5

1.3

205.02

244.40

u/ml

0.73

1047

6740

Chronic kidney disease

1082

6683

1.60

43.29

1.4

1.3

355.01

259.02

u/ml

1.27

1007

6174

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1479

10186

1.50

43.27

1.5

1.3

285.05

263.72

u/ml

0.25

1384

9499

Brachial plexus disorders

552

2997

1.97

43.15

1.4

1.3

140.52

224.94

u/ml

1.63

521

2805

Iron deficiency anaemia

1814

12696

1.43

43.08

1.5

1.3

300.26

223.37

u/ml

0.76

1684

11769

Venous thromboembolism

2119

14923

1.39

43.07

1.5

1.3

199.01

248.83

u/ml

1.70

1973

13868

Viral and other specified intestinal infections, including avohilmo

1527

10199

1.48

42.73

1.4

1.3

197.75

265.10

u/ml

1.83

1427

9471

Other disorders of eyelid

1691

11247

1.45

42.63

1.4

1.3

296.67

233.30

u/ml

0.48

1548

10415

Fibroblastic disorders

863

5282

1.68

42.63

1.3

217.92

259.39

u/ml

0.49

810

4874

Gonarthrosis,primary

3651

17245

1.30

42.53

1.3

226.05

247.53

u/ml

0.40

3389

16134

Noninfectious colitis NAS

676

3904

1.82

42.36

1.6

1.3

220.65

222.79

u/ml

0.02

627

3627

Other and unspecified disorders of vitreous body

1749

12175

1.44

42.29

1.3

159.71

226.86

u/ml

4.34

1626

11282

All-cause Heart Failure

1963

9812

1.42

42.11

1.3

326.01

267.91

u/ml

1.10

1831

9028

Presence of other functional implants

2276

11472

1.38

42.10

1.4

1.3

273.11

244.64

u/ml

0.45

2085

10691

Speech therapy

1110

7254

1.58

42.00

1.4

1.3

175.09

237.87

u/ml

2.04

1050

6706

Other and unspecified polyneuropathies, also in other diseases

738

4366

1.75

41.87

1.5

1.3

282.14

262.85

u/ml

0.14

693

4040

Hyperkinetic disorders

923

5672

1.67

41.83

1.4

1.3

292.14

268.79

u/ml

0.18

859

5293

Ganglion

1011

6478

1.62

41.82

1.4

1.3

189.83

227.93

u/ml

0.69

953

6023

Disorders of gallbladder, biliary tract and pancreas

4477

22418

1.26

41.81

1.4

1.3

202.27

243.24

u/ml

2.03

4204

20915

Heart failure and coronary heart disease

1338

6276

1.52

41.77

1.3

271.60

299.92

u/ml

0.46

1257

5777

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1603

11185

1.47

41.55

1.5

1.3

318.26

204.49

u/ml

0.77

1490

10440

Polycystic ovarian syndrome, consortium definition

3856

17529

1.29

41.31

1.4

1.3

192.03

192.96

u/ml

0.01

3589

16311

Other disorders of bone

974

6220

1.63

41.19

1.4

1.3

318.53

238.41

u/ml

0.35

929

5810

Other disorders of fluid, electrolyte and acid-base balance

1190

7434

1.55

41.08

1.5

1.3

330.54

250.20

u/ml

1.01

1106

6844

Disorders of vitreous body

2061

14399

1.39

40.99

1.3

164.34

239.05

u/ml

5.81

1916

13370

Other disorders of skin and subcutaneous tissue, not elsewhere classified

633

3617

1.83

40.95

1.5

1.3

329.19

232.75

u/ml

0.81

579

3350

Type of accident

1363

9347

1.50

40.82

1.5

1.3

274.77

254.65

u/ml

0.23

1274

8711

Otitis externa

1109

7302

1.57

40.78

1.5

1.3

337.59

252.54

u/ml

0.63

1025

6808

Sensorineural hearing loss

3024

15544

1.32

40.48

1.4

1.3

207.45

257.11

u/ml

2.12

2798

14515

Sequelae of external causes of morbidity and mortality

1104

7263

1.57

40.47

1.5

1.3

280.11

238.52

u/ml

0.19

1026

6726

Disorders of vitreous body and globe

2101

14669

1.38

40.35

1.3

162.84

238.61

u/ml

6.15

1954

13629

Other disorders involving the immune mechanism, not elsewhere classified

213

816

2.94

40.25

2.4

1.3

503.98

236.36

u/ml

0.87

192

763

Personality disorders, excluding more controls

1327

9065

1.51

40.19

1.4

1.3

269.17

215.45

u/ml

0.30

1216

8500

Hallux valgus (acquired)

1398

6831

1.50

40.19

1.4

1.3

165.73

250.42

u/ml

1.77

1305

6352

Dermatophytosis

620

3544

1.83

40.18

1.5

1.3

440.84

259.30

u/ml

1.54

578

3281

Cellulitis

1014

6572

1.60

39.91

1.4

1.3

326.07

245.96

u/ml

0.81

956

6124

Striking against or struck by other objects

1640

11666

1.44

39.87

1.5

1.3

282.98

287.78

u/ml

0.05

1543

10887

Benign paroxysmal vertigo

1236

8355

1.52

39.75

1.3

149.34

233.58

u/ml

4.97

1141

7710

Lichen ruber planus, wide definition including periferal and oral lichen planus

997

6455

1.60

39.55

1.4

1.3

238.59

209.68

u/ml

0.42

924

5974

Cholecystectomy

3115

20651

1.30

39.53

1.4

1.3

182.09

229.29

u/ml

2.89

2919

19257

Adhesive capsulitis of shoulder

687

4054

1.76

39.43

1.4

1.3

187.16

219.77

u/ml

0.44

644

3739

Hernia

4225

22630

1.26

39.28

1.4

1.3

244.28

240.02

u/ml

0.07

3949

21114

Intracranial injury

2639

18828

1.33

39.28

1.4

1.3

237.80

263.59

u/ml

0.47

2440

17535

Fissure and fistula of anal and rectal regions

1043

6822

1.58

39.18

1.4

1.3

181.85

287.62

u/ml

2.15

973

6353

Other extrapyramidal and movement disorders in other diseases

1060

6976

1.57

38.87

1.4

1.3

155.92

240.03

u/ml

3.99

991

6455

Other bacterial intestinal infections

760

4626

1.70

38.77

1.5

1.3

265.67

244.22

u/ml

0.22

701

4279

Seropositive rheumatoid arthritis

1002

6471

1.59

38.77

1.4

1.3

146.70

214.91

u/ml

3.63

936

5999

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

341

1618

2.23

38.56

1.5

1.3

290.19

231.96

u/ml

0.64

320

1495

Any operation in hilmo

168

254

3.51

38.51

1.3

1.1

384.54

217.13

u/ml

0.51

158

228

Conductive and sensorineural hearing loss

3243

16868

1.30

38.39

1.4

1.3

203.74

257.79

u/ml

2.49

3006

15752

Other and unspecified anaemias

1546

10259

1.44

38.29

1.4

1.3

484.14

231.76

u/ml

2.68

1423

9488

Inflammatory bowel disease

1487

10494

1.46

38.24

1.4

1.3

191.92

252.76

u/ml

1.36

1390

9803

Ischaemic heart disease, wide definition

2998

14301

1.31

38.21

1.4

1.3

216.31

256.01

u/ml

1.47

2775

13359

Pleural plaque with presence of asbestos

240

982

2.57

38.08

1.3

335.21

327.53

u/ml

0.03

223

886

Lichen planus, including avohilmo

837

5252

1.66

38.07

1.4

1.3

267.41

212.13

u/ml

0.81

772

4859

Other disorders of veins

1855

13367

1.40

38.04

1.3

189.33

225.31

u/ml

1.04

1741

12440

Lichen simplex chronicus

190

703

2.97

37.89

1.5

1.3

424.39

159.81

u/ml

1.75

176

648

Nutritional anaemias

2026

14327

1.37

37.69

1.4

1.3

363.36

226.19

u/ml

1.62

1886

13270

Other diseases of intestine

616

3571

1.79

37.65

1.5

1.3

336.82

272.24

u/ml

0.34

581

3291

Gout, FINNGEN

920

5848

1.60

37.58

1.4

1.3

412.87

300.65

u/ml

1.39

839

5414

Viral pneumonia (unknown virus, not influenza)

343

1653

2.21

37.54

1.6

1.3

166.90

263.21

u/ml

0.95

317

1527

Other specified/unspecified systemic involvement of connective tissue

333

1597

2.26

37.47

1.4

1.3

189.00

189.60

u/ml

0.00

308

1477

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

199

767

2.92

37.23

2.5

1.3

527.41

242.91

u/ml

0.86

180

716

Stomatitis and related lesions

974

6367

1.59

37.18

1.4

1.3

316.21

220.28

u/ml

0.50

914

5923

Cholelithiasis, broad definition with cholecystitis

3856

20609

1.26

37.17

1.4

1.3

186.18

233.39

u/ml

2.61

3620

19224

Other anaemias

1555

10357

1.43

37.08

1.4

1.3

483.36

233.58

u/ml

2.66

1432

9580

Cholelithiasis

3716

20303

1.27

37.00

1.4

1.3

182.81

232.54

u/ml

2.77

3491

18934

Otalgia

465

2511

1.97

36.95

1.5

1.3

144.57

253.58

u/ml

1.96

426

2336

Restless leg syndrome

678

4072

1.74

36.94

1.4

1.3

158.61

227.55

u/ml

1.65

635

3779

Dislocation, sprain and strain of joints and ligaments of knee

3042

21630

1.30

36.93

1.4

1.3

241.98

244.02

u/ml

0.03

2868

20172

Symptoms and signs involving the urinary system

3218

19148

1.29

36.78

1.4

1.3

218.38

250.83

u/ml

1.04

2991

17857

Disorders of muscles

469

2531

1.94

36.72

1.4

1.3

163.01

240.07

u/ml

2.04

438

2337

Osteoporosis with pathological fracture (FG)

295

1346

2.31

36.69

1.7

1.2

200.90

175.74

u/ml

0.26

269

1233

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1326

8045

1.49

36.68

1.4

1.3

340.46

262.80

u/ml

0.52

1221

7482

Injuries to the thorax

1845

13558

1.39

36.58

1.3

278.49

256.79

u/ml

0.28

1727

12613

Recurrent aphthous stomatitis , including avohilmo

712

4350

1.71

36.35

1.4

1.3

144.88

239.18

u/ml

3.06

665

4038

Hyperlipidaemia, other/unspecified

1387

8720

1.46

36.29

1.4

1.3

213.09

266.54

u/ml

1.53

1291

8060

Skin changes due to chronic exposure to nonionizing radiation

1255

7798

1.49

36.28

1.3

210.03

255.47

u/ml

0.78

1156

7147

Flat foot [pes planus] (acquired)

452

2428

1.96

36.04

1.4

1.3

176.78

223.15

u/ml

0.51

411

2256

Tinnitus

1015

6744

1.55

35.66

1.4

1.3

197.37

264.15

u/ml

1.15

929

6267

Disorders of ocular muscles, binocular movement, accommodation and refraction

2422

18471

1.33

35.58

1.4

1.3

203.34

245.46

u/ml

1.43

2247

17216

Other menopausal disorders

1254

4759

1.52

35.57

1.3

1.4

131.85

198.01

u/ml

3.46

1167

4431

Scabies, including avohilmo

849

5450

1.63

35.53

1.4

1.3

340.15

253.99

u/ml

0.75

795

5070

Other hammer toe(s) (acquired)

628

3367

1.75

35.50

1.4

1.3

227.20

228.36

u/ml

0.01

596

3084

Renal failure

1621

9955

1.41

35.30

1.4

1.3

338.01

272.60

u/ml

1.04

1503

9200

Actinic keratosis

1201

7476

1.49

35.28

1.3

212.97

254.85

u/ml

0.66

1106

6848

Keratitis

1621

11780

1.41

35.04

1.5

1.3

498.57

226.53

u/ml

3.07

1493

10956

Extrapyramidal and movement disorders

1500

10749

1.43

35.02

1.4

1.3

191.56

236.81

u/ml

0.88

1398

9942

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4264

22002

1.24

34.96

1.4

1.3

197.09

245.92

u/ml

2.83

3984

20574

Bacterial intestinal infections, IBD co-morbidities

754

4705

1.66

34.89

1.5

1.3

269.60

233.60

u/ml

0.41

694

4363

Artificial joint operation, meniscal resection

3751

19330

1.26

34.83

1.4

1.3

216.75

253.34

u/ml

1.01

3467

18072

Other/unspecified synovitis and tenosynovitis

513

2893

1.85

34.81

1.4

1.3

154.36

221.16

u/ml

1.58

488

2672

Plantar fascial fibromatosis

467

2564

1.91

34.78

1.3

158.05

209.93

u/ml

0.43

434

2371

Aplastic and other anaemias

1673

11145

1.40

34.78

1.4

1.3

465.71

235.52

u/ml

2.61

1538

10315

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1060

7171

1.54

34.75

1.4

1.3

278.22

173.17

u/ml

0.67

988

6667

Abnormal findings on diagnostic imaging of other body structures

614

3648

1.75

34.63

1.4

1.3

156.65

227.54

u/ml

2.74

559

3379

Hernia of abdominal wall

1840

13658

1.38

34.56

1.4

1.3

263.80

254.72

u/ml

0.11

1735

12702

Open wound of lower leg

683

4184

1.70

34.24

1.6

1.3

272.33

270.77

u/ml

0.01

643

3871

Rheumatoid arthritis, including avohilmo

1570

11393

1.41

34.18

1.3

155.87

229.76

u/ml

3.86

1472

10540

Coagulation defects, purpura and other haemorrhagic conditions

875

5693

1.59

34.03

1.5

1.3

249.65

237.66

u/ml

0.12

796

5288

ILD medications: pirfenidone

135

5.92

33.92

1.2

1.1

165.25

182.65

u/ml

0.09

122

Other viral diseases, not elsewhere classified

938

6190

1.57

33.87

1.5

1.3

264.50

255.48

u/ml

0.07

876

5790

Disorders of lens

2658

12784

1.31

33.87

1.4

1.3

343.77

222.41

u/ml

2.29

2459

11971

Adenomyosis (Endometriosis of uterus)

618

3699

1.74

33.83

1.4

1.3

126.63

227.09

u/ml

3.15

581

3418

Atopic conjunctivitis

284

1334

2.32

33.82

1.6

1.3

1088.09

191.10

u/ml

1.29

266

1240

Conduction disorders

1051

5650

1.52

33.55

1.4

1.3

249.23

301.66

u/ml

0.70

970

5225

Umbilical hernia

1127

7740

1.50

33.50

1.4

1.3

253.33

271.55

u/ml

0.29

1067

7237

Hypersensitivity pneumonitis due to organic dust

115

346

3.87

33.48

1.8

1.3

127.13

210.07

u/ml

0.64

103

315

Peritonsillar abscess

835

5382

1.60

33.48

1.3

1.2

234.36

209.42

u/ml

0.26

771

4985

Polyuria

846

5480

1.59

33.23

1.4

1.3

239.17

273.96

u/ml

0.36

784

5086

Pediculosis, acariasis and other infestations, including avohilmo

937

6234

1.56

33.20

1.4

1.3

320.19

267.27

u/ml

0.42

876

5801

Biological medication for rheuma

932

6201

1.56

33.05

1.4

1.3

130.92

237.85

u/ml

4.64

882

5790

Inflammatory disease of uterus

788

5068

1.63

32.90

1.4

1.3

141.81

169.15

u/ml

0.66

731

4716

Primary_lymphoid and hematopoietic malignant neoplasms

867

5664

1.57

32.75

1.5

1.3

444.36

266.30

u/ml

0.72

745

5268

Otitis media, unspecified

660

3739

1.71

32.72

1.5

1.3

218.83

279.83

u/ml

0.68

620

3460

Benign neoplasm: Colon, unspecified

907

5985

1.56

32.72

1.4

1.3

260.87

256.86

u/ml

0.04

833

5514

Neoplasms

3914

16687

1.25

32.71

1.4

1.3

254.54

260.87

u/ml

0.07

3643

15612

Other disorders of eye and adnexa

719

4524

1.66

32.69

1.4

1.3

217.83

222.17

u/ml

0.03

675

4223

Benign neoplasm of other and ill-defined parts of digestive system

718

4507

1.65

32.60

1.5

1.3

219.03

211.35

u/ml

0.06

675

4174

Other diseases of liver

819

5306

1.60

32.55

1.5

1.3

318.28

233.19

u/ml

0.71

779

4948

Cystic fibrosis with pulmonary manifestations

27.87

32.55

4.1

1.3

115.56

852.02

u/ml

0.54

Vasculitis limited to skin, not elsewhere classified

165

619

2.98

32.46

1.7

1.3

372.41

237.66

u/ml

0.59

157

569

Other pulmonary heart/vessel disease

204

840

2.60

32.44

1.5

1.2

264.16

253.89

u/ml

0.05

195

774

Other and unspecified vasculitis limited to skin

154

559

3.10

32.33

1.7

1.3

344.94

249.08

u/ml

0.37

148

514

Viral pneumonia (known virus, not influenza)

158

579

3.01

32.20

1.8

1.3

328.65

258.22

u/ml

0.25

139

531

Primary gonarthrosis, bilateral

1896

11910

1.36

32.16

1.4

1.3

184.01

243.10

u/ml

3.14

1761

11079

Gout, idiopatic and unspecified

796

5117

1.60

32.15

1.4

1.3

434.07

276.87

u/ml

2.01

732

4737

Coronary atherosclerosis

2271

10959

1.33

32.01

1.3

228.39

275.14

u/ml

1.32

2099

10196

Abnormal involuntary movements

608

3685

1.72

31.97

1.4

1.3

243.71

239.16

u/ml

0.03

577

3414

Lung diseases due to external agents

490

2789

1.82

31.90

1.5

1.3

258.67

254.28

u/ml

0.03

439

2568

Non-ischemic cardiomyopathy

1031

5531

1.51

31.64

1.3

373.49

255.56

u/ml

1.49

963

5088

Pneumocystosis, including avohilmo

124

404

3.51

31.63

2.1

1.2

222.92

283.31

u/ml

0.25

108

373

Pneumocystosis

124

404

3.51

31.63

2.1

1.2

222.92

283.31

u/ml

0.25

108

373

Zoster [herpes zoster]

731

4640

1.63

31.52

1.5

1.3

331.22

219.49

u/ml

1.36

668

4294

Other medical care

1883

11881

1.35

31.50

1.5

1.3

398.16

240.22

u/ml

3.68

1749

11015

Pain associated with micturition

556

3306

1.76

31.48

1.4

1.3

182.87

232.21

u/ml

0.55

518

3077

Diseases of tongue

265

1234

2.27

31.44

1.5

1.3

189.11

264.73

u/ml

0.76

250

1145

Sequelae with surgical and medical care as external cause

828

5415

1.58

31.39

1.5

1.3

290.37

253.22

u/ml

0.12

773

5021

Unspecified fall

2210

16751

1.32

31.27

1.4

1.3

291.21

251.82

u/ml

0.58

2053

15558

Heart failure and bmi 25plus

1172

5406

1.48

31.23

1.3

317.67

273.15

u/ml

0.45

1093

5006

Acute bronchiolitis

389

1891

1.99

31.04

1.7

1.3

385.22

392.91

u/ml

0.03

361

1760

Other/unspecified enthesopathies of lower limb, excluding foot

354

1847

2.02

31.03

1.4

1.3

118.82

223.00

u/ml

4.13

337

1716

Melanocytic naevi

1475

10783

1.40

31.00

1.4

1.3

166.21

243.51

u/ml

2.98

1398

10026

Pneumonia due to Streptococcus pneumoniae

209

890

2.52

31.00

1.7

1.3

224.59

184.45

u/ml

0.35

193

827

Localized swelling, mass and lump of skin and subcutaneous tissue

1376

9937

1.42

30.96

1.4

1.3

237.43

240.34

u/ml

0.03

1284

9228

Valvular heart disease excluding rheumatic fever

1703

9006

1.37

30.74

1.3

238.05

274.44

u/ml

0.72

1574

8373

Non-rheumatic valve diseases

1682

8876

1.38

30.63

1.3

239.76

273.72

u/ml

0.65

1553

8254

Coeliac disease

597

3652

1.71

30.53

1.4

1.3

224.54

223.34

u/ml

0.01

556

3403

Coxarthrosis [arthrosis of hip](FG)

2007

10478

1.34

30.49

1.4

1.3

279.92

251.89

u/ml

0.33

1845

9800

Other and unspecified follicular disorders

243

1121

2.36

30.28

1.6

1.3

314.31

240.00

u/ml

0.50

235

1044

Other follicular disorders

408

2255

1.92

30.22

1.5

1.3

317.44

244.62

u/ml

0.48

390

2099

Contact with and exposure to communicable diseases

1700

12709

1.37

30.19

1.5

1.3

201.10

235.73

u/ml

0.72

1590

11855

Cardiac murmurs and other cardiac sounds

412

2244

1.89

30.11

1.4

1.3

252.54

238.41

u/ml

0.06

381

2074

Viral warts, including avohilmo

1088

7600

1.48

29.96

1.4

1.3

329.33

232.29

u/ml

0.50

1012

7079

Universal erythroderma, KELA reimbursement

281

3.99

29.83

1.9

1.3

3090.88

270.80

u/ml

3.87

256

Cluster headache, wide

221

986

2.43

29.70

1.4

1.3

127.95

341.19

u/ml

1.56

210

921

Panic disorder

811

5361

1.57

29.69

1.4

1.3

340.26

202.26

u/ml

0.54

752

5008

Liquid cancers

1098

7262

1.46

29.37

1.5

1.3

381.66

264.89

u/ml

0.57

964

6749

Lichen planus

546

3294

1.73

29.26

1.4

1.3

290.58

194.05

u/ml

1.14

507

3041

Postviral fatigue syndrome

277

4.28

29.18

1.6

1.3

131.21

174.28

u/ml

0.28

252

Diseases of liver

1406

10289

1.40

29.15

1.4

1.3

288.73

252.57

u/ml

0.41

1324

9573

Injuries to the abdomen, lower back, lumbar spine and pelvis

1682

12460

1.36

29.03

1.4

1.3

280.26

248.57

u/ml

0.21

1577

11559

Abnormal blood-pressure reading, without diagnosis

203

876

2.46

29.00

1.5

1.3

517.83

236.75

u/ml

0.64

179

819

Disorders of tooth development and eruption

753

3967

1.59

28.93

1.4

1.3

237.36

247.04

u/ml

0.07

685

3711

Hallux rigidus

514

3053

1.74

28.92

1.3

147.88

241.08

u/ml

3.18

484

2812

Other condition

678

4331

1.63

28.87

1.5

1.3

301.48

244.50

u/ml

0.41

640

4040

Hypo-osmolality and hyponatraemia

637

3960

1.64

28.86

1.4

1.3

429.62

250.28

u/ml

1.44

585

3634

Diseases of arteries, arterioles and capillaries (FINNGEN)

890

4091

1.54

28.85

1.4

1.3

335.07

265.97

u/ml

0.97

819

3815

ILD medications: nintedanib

7.95

28.77

1.3

1.1

164.39

218.19

u/ml

0.18

Noninflammatory disorders of female genital tract

1972

7516

1.35

28.72

1.3

164.13

225.55

u/ml

2.30

1832

6980

Other CVD (FINNGEN)

415

1746

1.88

28.69

1.5

1.3

271.24

264.25

u/ml

0.03

389

1613

Spondylopathies (FG)

633

3986

1.65

28.56

1.4

1.3

211.71

259.82

u/ml

0.39

605

3719

Gonarthrosis, primary, with knee surgery

2056

12332

1.32

28.54

1.3

190.91

245.00

u/ml

1.79

1897

11491

694

4469

1.61

28.51

1.6

1.3

213.20

207.76

u/ml

0.05

636

4156

Other bursopathies

496

2930

1.75

28.49

1.3

252.91

238.87

u/ml

0.11

471

2696

Cluster headache, strict

211

941

2.43

28.47

1.4

1.3

132.25

351.18

u/ml

1.52

200

882

Cutaneous abscess, furuncle and carbuncle

1186

8498

1.43

28.13

1.5

1.3

304.23

239.84

u/ml

1.06

1110

7933

Hypertrophy of breast in women and men

1000

6970

1.49

28.12

1.4

1.3

320.71

184.10

u/ml

0.68

936

6509

Secondary right heart disease

180

750

2.57

27.97

1.5

1.3

287.21

264.35

u/ml

0.11

171

687

Other symptoms and signs involving the urinary system

432

2475

1.82

27.91

1.3

151.34

259.52

u/ml

3.35

404

2296

Injury of muscle and tendon at shoulder and upper arm level

1331

9727

1.40

27.77

1.3

229.28

273.15

u/ml

0.50

1234

9071

Neuralgia and neuritis, unspecified

256

1241

2.20

27.75

1.4

1.3

153.93

215.71

u/ml

0.96

239

1153

Weight loss

446

2587

1.80

27.74

1.5

1.3

391.10

262.54

u/ml

0.37

424

2392

Senile cataract

2281

10820

1.30

27.72

1.4

1.3

350.56

219.72

u/ml

2.10

2099

10100

Postmenopausal atrophic vaginitis

1052

3957

1.49

27.70

1.3

1.4

151.75

198.91

u/ml

1.29

977

3674

Trigger finger

608

3820

1.65

27.55

1.4

1.3

172.37

215.08

u/ml

0.90

572

3527

Achilles tendinitis

436

2518

1.80

27.37

1.5

1.3

224.83

255.08

u/ml

0.23

412

2344

Ocular pain

459

2704

1.79

27.36

1.4

1.3

219.84

227.49

u/ml

0.04

432

2520

Gout, strict definition

568

3509

1.66

27.28

1.3

461.57

286.58

u/ml

1.50

520

3247

Fracture of rib(s), sternum and thoracic spine

1118

7956

1.44

27.28

1.3

298.48

274.21

u/ml

0.23

1049

7405

Other cataract

1608

8951

1.36

27.22

1.4

1.3

344.02

225.66

u/ml

1.31

1493

8327

Gastroduodenal ulcer

782

5186

1.53

26.90

1.3

379.21

265.16

u/ml

0.99

737

4781

Lesion of ulnar nerve

581

3636

1.66

26.85

1.3

294.86

244.81

u/ml

0.37

537

3396

Injuries to the head

5254

26570

1.19

26.82

1.4

1.3

257.52

241.22

u/ml

0.41

4893

24801

Gout, unspecified

636

4054

1.61

26.79

1.4

1.3

428.23

274.35

u/ml

1.52

581

3753

Mental and behavioural disorders due to tobacco

422

2442

1.82

26.70

1.4

1.3

380.71

222.17

u/ml

1.73

401

2271

All kidney diseases

4568

25837

1.20

26.68

1.4

1.3

256.17

230.81

u/ml

0.73

4237

24131

Oxycodone

1357

8520

1.38

26.59

1.5

1.3

243.12

246.78

u/ml

0.04

1251

7924

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1519

11429

1.36

26.49

1.4

1.3

170.08

238.98

u/ml

1.87

1432

10621

Smoking dependency

422

2450

1.81

26.40

1.4

1.3

380.71

221.13

u/ml

1.74

401

2278

Otitis externa, unspecified

567

3554

1.67

26.37

1.4

1.3

280.21

240.53

u/ml

0.17

529

3314

Disorders of parathyroid gland

744

4879

1.55

26.22

1.4

1.3

167.55

210.23

u/ml

0.90

693

4471

Viral and other specified intestinal infections

1063

7388

1.44

26.11

1.5

1.3

223.64

282.05

u/ml

0.91

988

6867

Allergic colitis

187

835

2.54

25.98

1.8

1.4

605.78

399.11

u/ml

0.55

177

775

Ulcerative colitis

1086

7776

1.43

25.93

1.4

1.3

197.95

240.44

u/ml

0.62

1025

7255

Other metabolic disorders

656

4268

1.60

25.89

1.5

1.3

144.60

209.15

u/ml

1.72

616

3971

Chondropathies

711

4709

1.57

25.81

1.5

1.3

335.73

237.42

u/ml

0.32

683

4395

Drug-induced osteoporosis with pathological fracture

109

373

3.34

25.68

1.8

1.2

178.13

208.80

u/ml

0.18

104

345

Use of pramipexole

829

5661

1.51

25.56

1.4

1.3

203.17

226.26

u/ml

0.33

775

5222

Tumor necrosis factor alpha inhibitors

820

5610

1.52

25.50

1.4

1.3

124.13

234.48

u/ml

4.66

772

5240

Disorders of refraction and accommodation

1423

10638

1.37

25.39

1.4

1.3

194.52

236.37

u/ml

1.06

1321

9930

Diplopia

541

3376

1.66

25.37

1.4

1.3

272.62

256.41

u/ml

0.09

506

3129

Other/unspecified enthesopathies, not elsewhere classified

336

1838

1.91

25.32

1.4

1.3

204.27

247.45

u/ml

0.55

309

1689

Endometriosis of rectovaginal septum and vagina

360

2019

1.88

25.32

1.4

1.3

176.53

196.29

u/ml

0.14

337

1855

Hypertrophy of breast

909

6360

1.48

25.24

1.4

1.3

298.15

175.72

u/ml

0.54

853

5941

Chronic conjunctivitis

180

795

2.48

25.11

1.6

1.3

399.63

207.19

u/ml

1.07

170

736

Disorders of breast

2447

17310

1.27

25.06

1.4

1.3

217.96

179.95

u/ml

0.40

2285

16130

Transplanted organ and tissue status

439

2613

1.76

24.98

1.6

1.3

264.78

247.82

u/ml

0.10

403

2447

Atypical facial pain

272

1407

2.07

24.90

1.4

1.3

132.30

186.76

u/ml

0.93

250

1305

Other neurological diseases

2797

17627

1.25

24.88

1.4

1.3

221.77

248.31

u/ml

0.61

2559

16437

Hyperhidrosis

189

855

2.39

24.69

1.3

122.13

300.45

u/ml

1.09

177

801

Polymyalgia rheumatica

434

2572

1.74

24.63

1.4

1.3

244.48

223.42

u/ml

0.19

402

2350

Disorders of lipoprotein metabolism and other lipidaemias

3364

16894

1.22

24.57

1.3

210.71

249.08

u/ml

1.62

3145

15761

Spondyloarthritis

735

4944

1.53

24.44

1.5

1.3

205.54

248.94

u/ml

0.43

703

4604

Other and unspecified visual disturbances

477

2919

1.70

24.38

1.5

1.3

260.06

218.71

u/ml

0.24

442

2708

Other and unspecified local infections of skin and subcutaneous tissue

442

2652

1.74

24.38

1.5

1.3

582.07

239.53

u/ml

1.53

413

2465

Other diseases of the digestive system

1070

7707

1.41

24.27

1.4

1.3

311.59

268.52

u/ml

0.45

994

7136

Reactive arthropathies

366

2086

1.83

24.18

1.4

1.3

214.20

291.09

u/ml

0.62

346

1945

Disorders of oesophagus in diseases classified elsewhere

110

388

3.11

24.12

1.7

1.2

148.38

258.23

u/ml

0.75

359

Thyroiditis, ILD-related definition

565

3619

1.63

24.02

1.4

1.3

126.39

212.53

u/ml

2.33

526

3358

Other diseases of pericardium

194

894

2.30

23.90

1.6

1.3

197.17

262.28

u/ml

0.62

185

837

All chronic kidney diseases

2088

13160

1.28

23.89

1.4

1.3

331.64

261.19

u/ml

1.14

1935

12234

Psoriatic and enteropathic arthropathies

504

3145

1.66

23.71

1.3

176.00

224.59

u/ml

0.72

473

2944

Acne, including avohilmo

1271

7646

1.38

23.68

1.3

235.14

256.74

u/ml

0.26

1185

7099

Abnormal weight loss

393

2302

1.78

23.67

1.5

1.3

435.92

268.42

u/ml

0.45

373

2131

Ehlers-Danlos syndrome, including avohilmo

114

424

3.18

23.65

1.4

1.3

214.76

263.34

u/ml

0.21

109

397

Other local infections of skin and subcutaneous tissue

458

2797

1.70

23.58

1.5

1.3

586.02

251.03

u/ml

1.55

428

2597

Acute renal failure

723

4876

1.52

23.54

1.4

1.3

350.35

256.57

u/ml

0.86

666

4506

Other female pelvic inflammatory diseases

732

4976

1.52

23.52

1.4

1.3

157.83

174.81

u/ml

0.32

686

4608

Extreme obesity with alveolar hypoventilation

205

977

2.26

23.51

1.5

1.3

192.33

199.03

u/ml

0.07

196

908

Ehlers-Danlos syndrome

327

3.54

23.45

1.4

1.3

222.47

292.46

u/ml

0.26

304

Necrosis of pulp, including avohilmo

2759

22371

1.24

23.41

1.4

1.3

233.63

240.19

u/ml

0.07

2570

20945

Crohn disease

622

4093

1.58

23.38

1.4

1.3

160.59

245.17

u/ml

1.77

576

3814

Selective deficiency of immunoglobulin A [IgA]y

122

5.89

23.31

1.7

1.2

146.53

417.51

u/ml

0.60

114

Spontaneous rupture of synovium and tendon

319

1763

1.89

23.30

1.5

1.3

165.15

228.29

u/ml

0.86

298

1612

Protozoal diseases, including avohilmo

166

733

2.47

23.12

1.9

1.3

196.84

241.03

u/ml

0.28

145

679

Female infertility, cervical, vaginal, other or unspecified origin

1321

6304

1.37

23.02

1.4

1.3

134.84

210.92

u/ml

3.31

1234

5875

Other congenital malformations

482

3013

1.68

23.00

1.5

1.4

189.49

244.14

u/ml

0.73

445

2811

Paralytic ileus and intestinal obstruction

853

5958

1.46

22.97

1.4

1.3

209.05

265.35

u/ml

0.83

794

5507

Personality disorders

1327

10014

1.36

22.91

1.4

1.3

269.17

219.87

u/ml

0.27

1216

9347

Blepharochalasis

1042

7563

1.41

22.82

1.3

139.29

221.33

u/ml

5.31

945

6967

GI-bleeding

1052

7635

1.40

22.79

1.3

304.44

279.25

u/ml

0.23

980

7071

Scabies

261

1374

2.03

22.79

1.6

1.3

353.74

309.18

u/ml

0.14

242

1289

Other disorders of bladder

431

2608

1.71

22.77

1.3

216.47

290.48

u/ml

0.81

402

2409

Other abnormal uterine and vaginal bleeding

971

4971

1.44

22.73

1.4

1.3

166.93

215.00

u/ml

0.80

897

4609

Protozoal diseases

159

695

2.50

22.69

1.9

1.3

201.01

248.30

u/ml

0.28

139

643

Pacemaker

1062

7172

1.40

22.55

1.3

193.13

262.50

u/ml

2.62

983

6614

Purpura and other haemorrhagic conditions

555

3584

1.60

22.54

1.5

1.3

329.44

247.20

u/ml

0.74

492

3329

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1241

9280

1.37

22.53

1.4

1.3

211.04

267.96

u/ml

1.41

1155

8646

Superficial injury of wrist and hand

1026

7463

1.41

22.52

1.4

1.3

241.96

246.86

u/ml

0.03

952

6953

Fall on same level involving ice and snow

2526

20613

1.24

22.50

1.4

1.3

225.10

240.93

u/ml

0.31

2359

19206

Sequelae of injuries, of poisoning and of other consequences of external causes

998

7220

1.42

22.50

1.4

1.3

280.69

251.90

u/ml

0.24

944

6734

Trigeminal neuralgia

284

1541

1.95

22.38

1.4

1.3

147.60

188.96

u/ml

0.56

265

1428

Other disorders of conjunctiva

524

3344

1.62

22.32

1.4

1.3

278.33

205.90

u/ml

0.48

489

3092

Fitting and adjustment of other devices

1218

7973

1.37

22.29

1.4

1.3

190.75

241.11

u/ml

1.69

1141

7361

Inflammatory diseases of prostate (prostatitis)

401

2391

1.73

22.26

1.3

167.13

376.48

u/ml

6.47

373

2233

Ulcerative colitis, NAS

634

4231

1.55

22.25

1.4

1.3

212.15

248.99

u/ml

0.29

596

3946

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

235

1200

2.08

22.24

1.4

1.3

183.05

203.42

u/ml

0.18

223

1109

Other specified/unspecified soft tissue disorders

202

974

2.19

22.13

1.4

1.3

138.34

191.46

u/ml

0.79

186

898

Ulcer of lower limb, not elsewhere classified

485

3041

1.64

22.12

1.4

1.3

468.03

261.98

u/ml

3.18

449

2791

Problems related to lifestyle

490

3092

1.65

22.10

1.3

333.60

207.48

u/ml

1.86

457

2883

Psoriatic arthropathies

409

2465

1.72

22.07

1.3

182.31

258.67

u/ml

1.04

384

2298

Female infertility

1418

6445

1.35

21.91

1.3

134.64

210.91

u/ml

3.66

1324

6008

Degenerative diseases of the nervous system

475

5388

0.62

21.83

1.2

1.3

312.93

253.33

u/ml

0.68

430

4929

Nonalcoholic fatty liver disease

475

2990

1.66

21.83

1.5

1.3

307.90

228.92

u/ml

0.53

455

2783

Superficial injury of ankle and foot

645

4343

1.54

21.82

1.4

1.3

205.97

231.80

u/ml

0.37

618

4059

Female genital prolapse

1181

4831

1.39

21.78

1.4

129.64

199.09

u/ml

3.75

1114

4484

Colonic or urogenital fistula

1087

8013

1.39

21.77

1.4

1.3

178.24

262.20

u/ml

1.86

1016

7446

Other noninflammatory disorders of vulva and perineum

463

2896

1.66

21.75

1.4

1.3

391.12

228.17

u/ml

0.34

430

2685

Benign thyroid growths and nodules

1292

9066

1.35

21.71

1.3

117.68

219.42

u/ml

8.99

1193

8403

Endometriosis ASRM stages 1,2

916

6601

1.44

21.61

1.4

1.3

123.08

186.77

u/ml

1.70

846

6158

Injuries to the shoulder and upper arm

3702

24168

1.19

21.60

1.4

1.3

251.69

249.96

u/ml

0.03

3451

22537

N06DA Anticholinesterases

433

5353

0.61

21.52

1.2

1.3

247.43

252.82

u/ml

0.05

381

4889

Use of anticholinesterases

433

5353

0.61

21.52

1.2

1.3

247.43

252.82

u/ml

0.05

381

4889

Malignant neoplasm of digestive organs

733

8058

0.68

21.49

1.2

1.3

256.66

250.00

u/ml

0.05

668

7510

Seborrhoeic keratosis

912

6543

1.43

21.47

1.4

1.3

132.97

220.51

u/ml

5.57

847

6050

Neuromuscular dysfunction of bladder

370

2190

1.76

21.45

1.5

1.3

254.36

273.43

u/ml

0.10

337

2040

Suppurative and necrotic conditions of lower respiratory tract

228

1165

2.06

21.38

1.5

1.3

377.81

242.98

u/ml

0.43

215

1075

Anomalies of dental arch relationship, including avohilmo

1043

6932

1.40

21.35

1.4

1.3

209.29

245.91

u/ml

0.65

986

6443

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

219

1115

2.13

21.35

1.5

1.3

406.24

234.56

u/ml

0.89

211

1047

Seropositive rheumatoid arthritis, wide

1001

7305

1.40

21.34

1.4

1.3

146.82

218.71

u/ml

4.12

935

6733

Disorders of adult personality and behaviour

1402

10772

1.33

21.31

1.4

1.3

261.18

222.28

u/ml

0.22

1288

10056

Special screening examination for other diseases and disorders

435

2677

1.67

21.31

1.4

1.2

279.98

240.51

u/ml

0.45

405

2456

Examination and encounter for administrative purposes

260

1383

1.94

21.27

1.4

1.3

179.21

286.19

u/ml

1.61

244

1262

Melanocytic naevi, other sites/unspecified

408

2492

1.72

21.26

1.3

146.46

237.96

u/ml

1.24

386

2320

Hypopituitarism

354

2084

1.78

21.19

1.6

1.3

254.19

255.55

u/ml

0.01

332

1957

Other problems related to primary support group, including family circumstances

646

4266

1.54

21.15

1.5

1.3

316.53

225.56

u/ml

0.31

593

3995

Iridocyclitis

917

6611

1.42

21.12

1.4

1.3

240.40

217.84

u/ml

0.20

856

6147

Enterocolitis due to Clostridium difficile

391

2354

1.72

21.10

1.5

1.3

310.82

218.02

u/ml

0.98

352

2177

Unknown and unspecified causes of morbidity

289

1600

1.88

21.08

1.5

1.3

176.43

259.72

u/ml

0.69

268

1488

Malignant neoplasm of digestive organs, including Hilmo

861

8824

0.71

21.04

1.3

253.05

243.20

u/ml

0.10

782

8230

Viral warts

477

3035

1.64

20.96

1.7

1.3

525.57

221.92

u/ml

0.79

446

2827

Early lumbar disc prolapse, operated

484

3087

1.63

20.95

1.3

195.69

302.92

u/ml

1.40

462

2889

Faecal incontinence

342

1993

1.78

20.87

1.5

1.3

149.62

220.83

u/ml

1.38

323

1826

Myocarditis

212

1065

2.09

20.81

1.6

1.3

279.29

284.33

u/ml

0.02

204

981

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

202

1010

2.17

20.69

1.4

1.3

217.76

212.27

u/ml

0.04

194

939

Unspecific neurodegenerative disorder

606

6150

0.67

20.61

1.3

252.79

255.52

u/ml

0.03

541

5626

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

382

6004

0.60

20.59

1.3

280.43

250.21

u/ml

0.17

354

5576

Respiratory disorders in diseases classified elsewhere

331

3.20

20.56

1.6

1.2

137.96

274.03

u/ml

0.79

301

Benign neoplasm: Stomach

379

2286

1.73

20.54

1.6

1.3

135.48

210.80

u/ml

2.71

359

2107

Cluster headache, wide,, including avohilmo

287

1611

1.89

20.53

1.4

1.3

137.30

286.87

u/ml

1.69

272

1508

Impetigo

275

1526

1.93

20.53

1.7

1.3

1475.93

272.16

u/ml

3.76

259

1427

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1318

10087

1.33

20.51

1.4

1.3

216.91

238.79

u/ml

0.48

1238

9441

Glucagon-like peptide-1 (GLP-1) analogues

1318

10087

1.33

20.51

1.4

1.3

216.91

238.79

u/ml

0.48

1238

9441

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

974

7131

1.40

20.39

1.4

1.3

139.36

219.52

u/ml

5.28

909

6575

Pediculosis, acariasis and other infestations

298

1692

1.86

20.35

1.6

1.3

322.91

300.26

u/ml

0.07

277

1578

Erythema intertrigo

124

508

2.64

20.30

1.3

1.2

176.93

162.77

u/ml

0.12

114

470

Other symptoms and signs involving cognitive functions and awareness

1658

11553

1.29

20.25

1.4

1.3

224.96

255.27

u/ml

0.45

1546

10715

Other hearing loss

881

6132

1.42

20.23

1.4

1.3

180.47

270.23

u/ml

2.86

806

5649

Convulsions, not elsewhere classified

923

6616

1.41

20.19

1.4

1.3

366.20

290.04

u/ml

0.73

841

6180

Cluster headache, strict, including avohilmo

277

1552

1.90

19.99

1.4

1.3

140.94

290.43

u/ml

1.59

262

1455

Other congenital malformations, including avohilmo

655

4509

1.51

19.89

1.5

1.3

236.05

224.22

u/ml

0.08

607

4210

Other/unspecified seropositive rheumatoid arthritis

980

7212

1.39

19.86

1.4

1.3

142.91

219.33

u/ml

4.80

914

6650

Panniculitis affecting regions of neck and back

172

819

2.24

19.72

1.5

1.3

163.03

174.33

u/ml

0.13

164

764

Pleural effusion

469

3000

1.60

19.64

1.5

1.3

260.56

264.42

u/ml

0.03

438

2762

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

139

619

2.54

19.61

1.4

1.3

200.31

262.85

u/ml

0.39

131

580

Vulvovaginal ulceration/inflammation in other diseases

402

2506

1.69

19.60

1.4

1.3

174.38

183.56

u/ml

0.08

375

2339

Drug-induced osteoporosis

312

3.21

19.60

2.0

1.3

121.06

289.75

u/ml

0.90

285

Ankylosing spondylitis

346

2061

1.74

19.59

1.4

1.3

201.18

287.34

u/ml

0.46

329

1918

Infections with a predominantly sexual mode of transmission, including avohilmo

2070

15378

1.25

19.55

1.4

1.3

297.69

229.81

u/ml

0.64

1904

14382

Superficial injury of abdomen, lower back and pelvis

697

4862

1.48

19.50

1.4

1.3

189.66

243.44

u/ml

1.03

654

4533

Cerebrovascular diseases (FINNGEN)

1233

6551

1.34

19.35

1.4

1.3

239.13

245.40

u/ml

0.06

1156

6132

Postmenopausal bleeding

972

3692

1.41

19.31

1.3

1.4

159.95

202.48

u/ml

1.22

881

3427

Congenital malformations of the musculoskeletal system, not elsewhere classified

120

506

2.71

19.22

1.4

1.3

205.85

273.68

u/ml

0.35

112

472

Scoliosis

382

2351

1.69

19.19

1.3

171.93

240.86

u/ml

0.62

351

2175

Malignant neoplasm of breast

1248

10464

0.76

19.12

1.3

181.04

179.70

u/ml

0.02

1143

9796

Pneumonia derived septicemia

153

704

2.31

19.11

1.7

1.2

181.19

245.41

u/ml

0.43

140

646

Other CVD

614

4183

1.50

19.07

1.4

1.3

248.37

262.26

u/ml

0.09

572

3843

Malignant neoplasm of breast, HER2-negative

1246

10447

0.76

19.06

1.3

181.17

178.62

u/ml

0.04

1141

9780

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

8.02

19.05

2.2

1.2

126.27

626.59

u/ml

0.62

Alzheimer disease, including avohilmo

490

5156

0.65

18.96

1.2

1.3

253.81

248.39

u/ml

0.06

435

4701

Wegener granulomatosis

345

3.02

18.95

1.6

1.3

151.66

281.56

u/ml

0.76

318

Chronic ulcer of skin, not elsewhere classified

259

1435

1.88

18.91

1.5

1.3

411.17

232.16

u/ml

0.73

244

1329

Postprocedural disorders of nervous system

391

2441

1.68

18.91

1.4

1.3

197.08

215.92

u/ml

0.10

357

2292

Gastric ulcer

523

3454

1.55

18.90

1.3

315.78

275.67

u/ml

0.22

491

3181

Drug-induced cataract

137

611

2.46

18.89

1.7

1.3

249.16

218.61

u/ml

0.15

129

572

Specific personality disorders

1140

8668

1.35

18.82

1.3

270.69

214.82

u/ml

0.27

1042

8087

Oesophagitis

211

1098

2.01

18.77

1.6

1.3

289.89

209.92

u/ml

0.56

199

1021

Diseases of appendix

3313

25185

1.19

18.76

1.4

1.3

231.73

240.84

u/ml

0.14

3116

23524

Appendectomy

2964

23794

1.20

18.72

1.4

1.3

190.54

235.73

u/ml

1.91

2777

22236

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

431

2720

1.64

18.52

1.5

1.3

227.81

254.16

u/ml

0.19

405

2545

Other diseases of stomach and duodenum

244

1338

1.90

18.44

1.5

1.3

409.96

207.56

u/ml

0.50

231

1235

Appendicitis, broad definition

3287

25099

1.19

18.44

1.4

1.3

231.69

241.02

u/ml

0.14

3092

23445

Hyperparathyroidism

610

4138

1.49

18.41

1.3

165.15

204.02

u/ml

0.66

574

3800

Other disorders starting during childhood or adolecense, excluding more controls

291

1613

1.82

18.39

1.6

1.3

342.71

243.94

u/ml

0.55

267

1502

Cramp and spasm

238

1305

1.94

18.38

1.4

1.3

194.79

215.28

u/ml

0.18

226

1212

Endometriosis of ovary

742

4977

1.44

18.36

1.3

138.05

211.00

u/ml

1.81

695

4636

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

188

949

2.09

18.32

1.6

1.3

189.19

252.19

u/ml

0.63

178

881

Malignant neoplasm of breast, HER2-negative, including Hilmo

1292

10654

0.76

18.32

1.3

179.40

179.23

u/ml

0.00

1188

9976

Malignant neoplasm of breast, including Hilmo

1292

10652

0.76

18.31

1.3

179.40

179.26

u/ml

0.00

1188

9974

Adjustment and management of implanted device

533

3560

1.53

18.30

1.3

174.17

281.40

u/ml

4.51

498

3277

Statin medication

3135

14895

1.20

18.23

1.3

217.16

237.18

u/ml

0.24

2943

13942

Perforation of tympanic membrane

411

2608

1.63

18.21

1.5

1.3

266.65

244.01

u/ml

0.12

381

2409

Erosion of teeth , including avohilmo

1293

10045

1.32

18.17

1.4

1.3

238.61

232.13

u/ml

0.07

1218

9365

Acute appendicitis, no complications

2524

20938

1.21

18.12

1.4

1.3

210.24

237.35

u/ml

0.71

2368

19591

Varicose veins

2310

14376

1.23

18.11

1.3

199.94

237.00

u/ml

0.91

2146

13384

Pneumothorax

253

1413

1.86

17.99

1.6

1.3

290.61

236.30

u/ml

0.45

236

1305

Renal tubulo-interstitial diseases

3763

23708

1.17

17.99

1.4

1.3

270.73

233.62

u/ml

1.04

3480

22123

SLE (Finngen)

179

900

2.13

17.94

1.2

1.3

125.70

181.35

u/ml

0.86

162

829

Acute nasopharyngitis (common cold)

466

3022

1.58

17.94

1.4

1.3

439.15

282.04

u/ml

0.87

438

2846

Olecranon bursitis

220

1177

1.95

17.94

1.5

1.3

601.74

296.53

u/ml

0.75

208

1081

Disorders of continuity of bone

457

2986

1.59

17.90

1.5

1.3

182.91

227.96

u/ml

0.60

421

2776

Complications of internal orthopaedic prosthetic devices, implants and grafts

732

5221

1.43

17.87

1.4

1.3

219.56

235.84

u/ml

0.23

668

4787

Hypokalaemia

457

2978

1.58

17.86

1.5

1.3

258.40

236.09

u/ml

0.11

430

2754

Alzheimer disease

398

4459

0.63

17.85

1.2

1.3

255.58

258.60

u/ml

0.03

356

4067

Diseases of male genital organs

1682

6701

1.28

17.82

1.4

368.07

369.55

u/ml

0.01

1576

6285

Gluteal tendinitis

200

1045

2.02

17.77

1.4

1.3

169.52

159.17

u/ml

0.08

189

966

Superficial injury of hip and thigh

557

3785

1.51

17.70

1.3

201.24

262.99

u/ml

1.12

524

3491

Other deformities of toe(s)

160

773

2.20

17.70

1.3

167.86

232.60

u/ml

0.55

147

708

Other (seronegative) rheumatoid arthritis, wide

696

4940

1.44

17.65

1.4

1.3

149.17

211.13

u/ml

2.90

652

4561

Barrett oesophagus

190

976

2.04

17.61

1.4

1.3

285.97

239.76

u/ml

0.21

174

910

Anosmia

108

421

2.62

17.61

1.4

1.3

286.00

270.41

u/ml

0.05

101

382

IBD patients in KELA-register

1010

7617

1.36

17.59

1.3

214.24

254.68

u/ml

0.49

947

7112

Fracture of foot, except ankle

1111

8495

1.34

17.53

1.5

1.3

203.19

232.29

u/ml

0.52

1047

7919

Pure hypercholesterolaemia

2893

15470

1.20

17.44

1.3

220.58

249.32

u/ml

0.81

2705

14411

Superficial injury of shoulder and upper arm

518

3490

1.53

17.44

1.4

1.3

202.32

255.20

u/ml

0.71

493

3252

Reactive arthropathies, FINNGEN

309

1849

1.74

17.42

1.4

1.3

210.23

254.81

u/ml

0.36

292

1722

Nontoxic multinodular goitre

701

4996

1.44

17.35

1.4

1.3

119.00

202.86

u/ml

5.15

647

4593

Any dementia

585

5829

0.68

17.23

1.3

263.75

249.97

u/ml

0.16

525

5339

Monoamine oxidase A inhibitors

435

2829

1.58

17.21

1.4

1.3

183.91

227.27

u/ml

0.72

396

2641

Hypotension

512

3438

1.52

17.16

1.5

1.3

271.10

266.06

u/ml

0.03

475

3155

Convalescence

249

1412

1.86

17.13

1.5

1.3

219.46

191.66

u/ml

0.16

230

1313

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2822

18533

1.20

17.05

1.3

187.04

207.51

u/ml

0.55

2645

17310

Tobacco use

263

1521

1.82

16.99

1.3

348.59

272.82

u/ml

0.48

247

1411

Other peripheral vertigo

358

2237

1.66

16.95

1.4

1.3

100.57

206.85

u/ml

6.24

338

2068

Other benign neoplasms of skin

1402

11082

1.29

16.92

1.3

207.75

241.76

u/ml

0.65

1306

10269

Crohn's disease of small intestine

335

2068

1.70

16.88

1.4

1.3

139.46

248.89

u/ml

1.49

315

1925

Psychotic depression

256

1465

1.82

16.86

1.3

290.14

227.52

u/ml

0.30

230

1362

Other and unspecified disorders of white blood cells

186

969

2.04

16.81

1.8

1.3

296.91

228.69

u/ml

0.27

164

900

Persistent mood disorders

785

5737

1.40

16.77

1.3

248.24

205.65

u/ml

0.54

722

5355

Schizophrenia

300

4882

0.60

16.76

1.2

1.3

684.73

252.14

u/ml

0.61

256

4589

Chondrocostal junction syndrome [Tietze]

195

1036

2.01

16.72

1.5

1.3

154.20

208.62

u/ml

0.71

189

960

Misadventures to patients during surgical and medical care

564

3895

1.49

16.71

1.5

1.3

273.00

231.57

u/ml

0.35

528

3615

Acute and subacute iridocyclitis

748

5429

1.41

16.70

1.4

1.3

228.20

223.54

u/ml

0.03

702

5055

Liquid cancers, including Hilmo

1268

8720

1.30

16.66

1.5

1.3

354.68

256.95

u/ml

0.55

1122

8125

Acute appendicitis

3089

24495

1.18

16.64

1.4

1.3

216.70

238.91

u/ml

0.58

2905

22897

STROKE

2130

11807

1.23

16.62

1.4

1.3

234.26

247.49

u/ml

0.22

1961

11058

Adalimumab

492

3325

1.54

16.58

1.4

1.3

102.18

246.97

u/ml

5.11

470

3106

Morphin

341

2.77

16.58

1.4

1.3

102.93

193.17

u/ml

1.75

313

Acute gastritis

265

1540

1.78

16.47

1.4

1.3

266.85

229.98

u/ml

0.27

243

1427

Sequelae of other external causes

253

1458

1.82

16.42

1.6

1.3

276.15

219.52

u/ml

0.52

235

1356

Procreative management

1594

10552

1.27

16.41

1.5

1.3

177.60

260.14

u/ml

4.19

1482

9859

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

586

4081

1.48

16.40

1.5

1.3

349.77

252.43

u/ml

0.41

546

3812

Other specified/unspecified inflammatory spondylopathies

229

1284

1.88

16.39

1.4

1.3

177.38

264.74

u/ml

0.47

218

1192

Unstable angina pectoris

1017

6044

1.34

16.37

1.4

1.3

223.91

302.29

u/ml

1.16

938

5573

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1856

9535

1.25

16.34

1.4

1.3

212.51

193.65

u/ml

0.20

1753

8911

Benign neoplasm: Ascending colon

477

3200

1.53

16.31

1.5

1.3

210.97

230.10

u/ml

0.23

440

2960

Ventral hernia

861

6408

1.37

16.28

1.4

1.3

273.19

243.61

u/ml

0.21

810

5939

Other and unspecified epidermal thickening

137

648

2.28

16.23

1.5

1.3

221.21

229.66

u/ml

0.04

131

598

Other congenital malformations of skin

218

1214

1.92

16.21

1.6

1.3

148.77

289.73

u/ml

1.17

201

1133

Other peripheral vascular diseases

350

2202

1.65

16.21

1.3

160.15

190.39

u/ml

0.49

331

2046

Crohn's disease NAS

305

1859

1.72

16.18

1.4

1.3

159.97

204.79

u/ml

0.66

286

1739

Secondary hypertension

289

1701

1.73

16.14

1.2

1.3

203.72

297.29

u/ml

1.21

270

1574

Glomerular diseases

652

4650

1.44

16.14

1.4

1.3

373.75

276.74

u/ml

0.50

593

4330

Non-Hodgkin lymphoma, all, including Hilmo

443

2934

1.55

16.09

1.5

1.3

652.63

242.93

u/ml

0.96

385

2726

Atrophic disorders of skin

669

4802

1.43

16.08

1.4

1.3

184.12

200.58

u/ml

0.21

621

4455

Hordeolum and other deep inflammation of eyelid

288

1733

1.74

16.06

1.5

1.3

267.11

252.83

u/ml

0.06

259

1607

Car occupant injured in other and unspecified transport accidents

845

6298

1.37

16.05

1.4

1.3

189.98

234.28

u/ml

1.00

794

5873

Anterior Iridocyclitis

789

5815

1.39

16.04

1.4

1.3

238.61

233.76

u/ml

0.03

739

5418

Follicular cysts of skin and subcutaneous tissue

716

5195

1.41

16.03

1.3

206.33

257.33

u/ml

1.04

664

4837

Stenosis and insufficiency of lacrimal passages

361

2291

1.63

16.01

1.4

1.3

183.72

194.69

u/ml

0.12

338

2117

Other erythematous conditions

169

867

2.07

16.00

1.4

1.3

625.91

210.55

u/ml

0.77

155

801

Streptococcal septicaemia

317

1948

1.68

15.96

1.5

1.3

189.70

220.25

u/ml

0.37

288

1810

Postprocedural endocrine and metabolic disorders, not elsewhere classified

563

3932

1.48

15.87

1.5

1.3

140.63

188.31

u/ml

1.94

529

3665

Polyarthritis, unspecified

158

792

2.11

15.86

1.4

1.3

148.54

235.20

u/ml

1.10

150

730

Other and unspecified disorders of skin and subcutaneous tissue

266

1571

1.77

15.82

1.5

1.3

225.30

198.11

u/ml

0.23

233

1453

Other abnormal immunological findings in serum

126

587

2.35

15.74

1.4

1.3

227.22

233.53

u/ml

0.03

121

552

Chalazion

474

3206

1.53

15.73

1.4

1.3

384.17

255.45

u/ml

0.46

445

2973

Spinal instabilities

134

636

2.25

15.68

1.3

224.33

180.57

u/ml

0.20

123

592

Nontoxic goitre/thyroid nodule

1094

8480

1.31

15.58

1.3

111.22

190.81

u/ml

8.82

1006

7827

Acne

595

4196

1.46

15.57

1.3

260.88

261.96

u/ml

0.01

557

3901

Congenital malformations and deformations of the musculoskeletal system

480

3261

1.53

15.47

1.5

1.4

280.45

260.87

u/ml

0.10

445

3042

conjunctival haemorrhage

282

1699

1.72

15.46

1.4

1.3

249.05

211.54

u/ml

0.16

266

1576

Phlebitis and thrombophlebitis (not including DVT)

847

6345

1.36

15.42

1.4

1.3

180.74

244.09

u/ml

1.78

795

5898

Pericarditis

144

704

2.15

15.41

1.5

1.3

440.76

261.52

u/ml

0.55

138

660

Mature T/NK-cell lymphomas, hilmo

260

3.06

15.38

1.7

1.2

1980.14

277.71

u/ml

0.64

242

Streptococcal septicaemia, including avohilmo

324

2021

1.65

15.38

1.5

1.3

203.18

218.36

u/ml

0.16

295

1875

Presence of other devices

761

5513

1.38

15.28

1.3

202.64

257.55

u/ml

1.09

706

5106

Inflammatory bowel disease, strict (require KELA)

1010

7775

1.33

15.27

1.3

214.24

241.29

u/ml

0.31

947

7255

Leisure time condition

733

5385

1.39

15.25

1.5

1.3

259.30

254.21

u/ml

0.05

681

5006

Bruxism

126

597

2.33

15.24

1.7

1.3

176.14

216.62

u/ml

0.29

118

558

Substance use, excluding alcohol

853

6417

1.36

15.21

1.4

1.3

345.71

259.91

u/ml

1.00

800

6009

Calcific tendinitis of shoulder

239

1386

1.80

15.16

1.4

1.3

115.92

193.06

u/ml

2.33

223

1279

Other obstetric conditions, not elsewhere classified

1882

9780

1.24

15.11

1.4

1.3

211.12

191.39

u/ml

0.21

1774

9144

Emotionally unstable personality disorder

643

4647

1.43

15.10

1.3

317.57

214.79

u/ml

0.28

588

4343

Other disorders of the musculoskeletal system and connective tissue

549

3847

1.47

15.09

1.4

1.3

204.89

225.93

u/ml

0.27

513

3577

L04AC Interleukin inhibitors

323

2035

1.66

15.09

1.5

1.3

223.64

205.39

u/ml

0.12

305

1907

Other strabismus

987

7561

1.33

15.07

1.4

1.3

218.21

230.81

u/ml

0.15

920

7062

Disturbances of smell and taste

197

1085

1.92

15.06

1.3

215.49

202.95

u/ml

0.07

183

999

Alopecia areata

160

828

2.09

15.04

1.7

1.3

564.25

222.89

u/ml

1.58

154

781

Hypertensive heart and/or renal disease

737

3925

1.39

15.01

1.3

255.37

256.88

u/ml

0.02

686

3595

Fracture at wrist and hand level

1440

11555

1.26

14.93

1.4

1.3

388.09

264.12

u/ml

1.21

1347

10777

Polyp of the female genital tract

1209

5351

1.30

14.83

1.3

124.93

212.98

u/ml

4.31

1130

4974

Short Achilles tendon (acquired)

135

657

2.19

14.82

1.6

1.2

143.92

197.70

u/ml

0.50

126

603

Abrasion of teeth

1549

12591

1.25

14.81

1.4

1.3

169.60

238.33

u/ml

2.73

1438

11750

Obsessive-compulsive disorder

359

2326

1.61

14.77

1.3

153.65

217.88

u/ml

1.86

333

2166

Alzheimer’s disease, strict definition

285

3706

0.61

14.71

1.2

1.3

255.28

250.78

u/ml

0.04

254

3376

Malignant neoplasm of breast, ER-positive, including Hilmo

905

8789

0.75

14.69

1.3

198.40

177.00

u/ml

0.32

826

8210

Arthropathies in other diseases classified elsewhere

152

773

2.08

14.68

1.4

1.3

336.47

273.11

u/ml

0.13

140

710

Malignant neoplasm of breast, HER-positive

902

8773

0.75

14.68

1.3

198.17

177.07

u/ml

0.31

823

8194

Corticotropin deficiency

220

3.31

14.64

2.0

1.3

123.79

247.06

u/ml

0.82

205

Other or unspecified ileus, impaction or obstruction

562

3965

1.44

14.61

1.4

1.3

175.00

269.44

u/ml

2.73

528

3661

Open wound of wrist and hand

1880

15059

1.22

14.53

1.4

1.3

296.63

259.43

u/ml

0.47

1758

14049

Dysplasia of cervi uteri

1098

6013

1.31

14.51

1.3

227.47

208.95

u/ml

0.18

1020

5619

Other and unspecified erythematous conditions

153

786

2.07

14.50

1.4

1.3

676.59

222.13

u/ml

0.76

140

725

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1262

9929

1.28

14.40

1.3

337.08

212.54

u/ml

0.84

1172

9307

Ulcer of oesophagus

213

1209

1.82

14.40

1.4

1.3

314.89

257.87

u/ml

0.24

204

1116

Haemorrhage in early pregnancy

1377

10783

1.27

14.35

1.3

164.20

189.63

u/ml

0.45

1285

10071

Deep endometriosis

438

2981

1.53

14.35

1.4

1.3

161.29

164.05

u/ml

0.02

409

2767

Other otitis externa (chronic)

297

1854

1.67

14.34

1.5

1.3

227.53

209.09

u/ml

0.12

277

1725

Superficial injury of head

940

7213

1.32

14.31

1.4

1.3

213.67

248.87

u/ml

0.70

877

6683

Other noninflammatory disorders of vagina

340

2189

1.61

14.31

1.3

145.81

242.78

u/ml

1.23

310

2018

Presbycusis

330

2069

1.60

14.26

1.3

224.12

265.42

u/ml

0.38

294

1889

AV-block

488

2869

1.48

14.15

1.2

1.3

229.35

294.86

u/ml

0.92

443

2638

Dementia

733

6733

0.74

14.13

1.3

326.39

255.41

u/ml

0.74

661

6167

Fall on and from stairs and steps

1032

8046

1.31

14.11

1.4

1.3

219.19

237.75

u/ml

0.34

957

7473

Other maternal disorders predominantly related to pregnancy

2843

15268

1.18

14.10

1.3

167.55

194.41

u/ml

0.79

2645

14247

Anogenital herpesviral [herpes simplex] infection, including avohilmo

591

4267

1.43

14.02

1.5

1.3

358.28

213.37

u/ml

0.40

551

3982

Other/unspecified rheumatoid arthritis

420

2836

1.52

14.01

1.4

1.3

148.60

199.89

u/ml

1.49

398

2618

Raynaud syndrome

412

2783

1.54

14.00

1.3

139.50

223.67

u/ml

1.48

385

2593

Benign neoplasm of mouth and pharynx

407

2735

1.53

13.99

1.4

1.3

217.34

222.43

u/ml

0.04

379

2539

Contraceptive management

1938

11275

1.22

13.96

1.3

168.85

259.99

u/ml

5.90

1827

10561

Benign neoplasm: Rectum

590

4243

1.42

13.95

1.3

211.97

240.90

u/ml

0.24

538

3921

Speech and linguistic disorders, excluding more controls

405

2551

1.54

13.95

1.5

1.3

390.39

249.55

u/ml

0.46

372

2389

Explicit bacterial Sepsis

373

2458

1.56

13.93

1.5

1.3

231.24

248.08

u/ml

0.14

339

2279

Other keratitis

489

3411

1.48

13.93

1.4

1.3

529.65

220.77

u/ml

2.48

452

3180

Inflammatory diseases of the central nervous system

350

2286

1.59

13.86

1.5

1.3

238.56

244.77

u/ml

0.03

330

2128

Pleural plaque without asbestos

112

517

2.27

13.84

1.5

1.3

460.14

248.82

u/ml

0.67

106

476

Volume depletion

304

1914

1.63

13.83

1.3

389.85

257.15

u/ml

0.87

283

1763

Systemic lupus erythematosus

179

987

1.93

13.77

1.2

1.3

125.70

187.96

u/ml

0.84

162

911

Algoneurodystrophy

180

996

1.93

13.77

1.5

1.3

153.70

215.52

u/ml

0.82

166

931

Other pleural conditions

296

1854

1.64

13.76

1.4

1.3

191.03

249.98

u/ml

0.75

284

1714

Benign neoplasm: Sigmoid colon

619

4499

1.40

13.73

1.3

331.55

246.71

u/ml

0.44

574

4145

Explicit bacterial Sepsis, including avohilmo

380

2523

1.55

13.71

1.5

1.3

241.90

248.72

u/ml

0.05

346

2336

Dissociative [conversion] disorders

208

1203

1.83

13.62

1.5

1.3

148.93

199.80

u/ml

0.75

195

1129

Hypertensive Heart Disease

654

3612

1.39

13.57

1.3

242.21

262.84

u/ml

0.24

608

3306

Superficial injury of thorax

571

4107

1.42

13.55

1.3

221.11

256.24

u/ml

0.50

529

3821

Cardiodefibrillation

999

7762

1.30

13.53

1.3

278.86

286.04

u/ml

0.06

943

7173

Benign neoplasm: Transverse colon

367

2432

1.55

13.46

1.4

1.3

180.77

239.68

u/ml

1.00

337

2250

Presence of cardiac and vascular implants and grafts

1254

7350

1.27

13.45

1.3

198.53

283.66

u/ml

4.10

1160

6821

Other disorders of kidney and ureter

454

3141

1.48

13.42

1.4

1.3

191.60

243.66

u/ml

0.99

428

2897

Synovial cyst of popliteal space [Baker]

251

1522

1.70

13.42

1.3

216.41

225.39

u/ml

0.06

239

1392

Excessive earwax

2433

18811

1.18

13.40

1.4

1.3

264.25

254.87

u/ml

0.11

2279

17494

Benign neoplasm: Rectum, anus and anal canal

649

4772

1.39

13.39

1.3

205.22

246.63

u/ml

0.42

596

4402

Pyogenic arthritis

227

1341

1.75

13.37

1.3

337.44

276.83

u/ml

0.31

214

1236

Perioral dermatitis

141

730

2.09

13.31

1.7

1.3

195.51

312.24

u/ml

0.44

131

680

Other coagulation defects

334

2182

1.59

13.30

1.5

1.3

128.38

236.20

u/ml

1.66

316

2043

Radial styloid tenosynovitis [de Quervain]

255

1562

1.70

13.30

1.3

158.80

201.55

u/ml

0.44

242

1442

Effects of foreign body entering through natural orifice

950

7389

1.31

13.29

1.4

1.3

222.74

297.63

u/ml

1.45

898

6906

Benign neoplasm: Caecum

360

2384

1.55

13.25

1.4

1.3

201.38

214.37

u/ml

0.13

327

2203

ILD and respiratory illness in diseases classified elsewhere

117

4.16

13.23

1.6

1.3

238.16

344.66

u/ml

0.27

112

Bacterial, viral and other infectious agents, including avohilmo

389

2626

1.53

13.21

1.6

1.3

224.05

238.75

u/ml

0.14

369

2456

Excessive vomiting in pregnancy

431

2981

1.50

13.15

1.4

1.3

97.49

219.50

u/ml

2.18

411

2787

Haemorrhage, not elsewhere classified

132

662

2.08

13.14

1.3

1.2

244.55

232.68

u/ml

0.04

122

612

Persons encountering health services for specific procedures, not carried out

371

2481

1.54

13.14

1.4

1.3

605.14

227.46

u/ml

0.86

335

2312

Sacrococcygeal disorders, not elsewhere classified

152

807

2.00

13.11

1.4

1.3

207.47

210.10

u/ml

0.01

145

751

Hyperplasia of prostate

975

4233

1.31

13.09

1.4

1.3

286.11

361.32

u/ml

1.12

902

3967

Other/unspecified soft tissue disorders related to use, overuse and pressure

139

716

2.06

13.07

1.4

1.3

119.30

201.71

u/ml

1.08

130

653

Any dementia, excluding more controls

548

5220

0.71

13.07

1.3

266.28

236.37

u/ml

0.39

490

4786

False labour

1668

8551

1.23

13.05

1.4

1.3

159.69

206.33

u/ml

0.99

1568

7988

104

4.36

13.03

1.6

1.2

250.24

379.51

u/ml

0.30

Major coronary heart disease event excluding revascularizations

1838

10082

1.21

12.99

1.4

1.3

285.73

282.89

u/ml

0.03

1693

9365

Calculus of kidney and ureter

990

7755

1.30

12.98

1.4

1.3

258.39

273.45

u/ml

0.15

930

7234

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

336

2207

1.57

12.95

1.4

1.3

217.29

276.73

u/ml

0.64

313

2059

Other disorders of pigmentation

200

1161

1.81

12.83

1.4

1.3

182.47

198.83

u/ml

0.13

188

1067

Infections with a predominantly sexual mode of transmission

1477

12117

1.24

12.78

1.4

1.3

254.05

215.40

u/ml

0.52

1366

11336

Dementia, including avohilmo

817

7267

0.76

12.78

1.3

309.68

253.90

u/ml

0.61

739

6661

Scleritis and episcleritis

290

1855

1.63

12.78

1.5

1.3

168.86

181.75

u/ml

0.14

276

1723

Fracture of lower leg, including ankle

2212

18484

1.19

12.73

1.4

1.3

233.82

251.36

u/ml

0.31

2070

17203

Panniculitis, unspecified

207

3.09

12.72

1.3

1.2

78.88

287.44

u/ml

1.10

190

Sacroiliitis, not elsewhere classified

228

1376

1.73

12.68

1.3

184.18

265.11

u/ml

0.55

217

1279

Bicipital tendinitis

187

1066

1.83

12.67

1.4

1.2

141.00

234.05

u/ml

1.09

177

982

Acute lymphadenitis

275

1741

1.65

12.65

1.6

1.3

361.76

253.32

u/ml

0.54

249

1614

Corneal ulcer

744

5641

1.35

12.64

1.5

1.3

446.75

227.73

u/ml

0.89

691

5250

Iron deficiency

192

1113

1.84

12.64

1.6

1.3

196.64

270.24

u/ml

0.38

178

1028

Other disorders of nervous system

257

1597

1.67

12.63

1.4

1.3

325.16

199.33

u/ml

0.52

235

1485

Glomerular disorders in diseases classified elsewhere

406

2788

1.50

12.53

1.3

442.84

245.71

u/ml

0.72

362

2589

Uterine polyps

1107

5118

1.28

12.48

1.4

1.3

121.07

215.74

u/ml

4.67

1038

4753

Diseases of arteries, arterioles and capillaries

2201

13708

1.19

12.45

1.3

282.42

250.81

u/ml

0.64

2038

12740

Cerebral palsy and other paralytic syndromes

437

3049

1.47

12.45

1.4

1.3

199.77

251.99

u/ml

0.64

406

2840

DVT of lower extremities

617

4555

1.38

12.43

1.5

1.3

197.83

246.25

u/ml

0.81

576

4222

Left bundle-branch block

239

1460

1.69

12.41

1.3

249.91

235.31

u/ml

0.06

224

1342

Heterophoria

381

2600

1.52

12.38

1.5

1.3

265.26

234.94

u/ml

0.17

354

2414

Autonomic disorders

121

608

2.13

12.32

1.5

1.3

113.04

191.17

u/ml

1.49

108

568

Right bundle-branch block

127

644

2.05

12.30

1.6

1.3

427.97

291.64

u/ml

0.33

118

605

Thyrotoxicosis, other and/or unspecified

823

6355

1.32

12.27

1.4

1.3

173.82

220.23

u/ml

1.22

776

5912

Other superficial mycoses, including avohilmo

496

3555

1.44

12.25

1.4

1.3

195.67

242.68

u/ml

0.66

468

3307

Other disorders of breast

622

4626

1.38

12.25

1.4

1.3

176.29

182.50

u/ml

0.07

582

4304

Strabismus

1119

8949

1.27

12.23

1.4

1.3

206.48

244.10

u/ml

0.62

1043

8334

Idiopathic gout

281

1794

1.61

12.18

1.4

1.3

402.13

272.95

u/ml

1.03

265

1660

Contusion of other and unspecified parts of foot

269

1712

1.64

12.15

1.4

1.3

227.73

231.35

u/ml

0.03

257

1595

Medial epicondylitis

170

957

1.87

12.14

1.4

1.3

135.17

194.01

u/ml

0.89

158

876

Chronic suppurative otitis media, including avohilmo

320

2112

1.57

12.14

1.6

1.3

385.25

274.01

u/ml

0.46

302

1965

Ulcer of vagina/vulva

152

832

1.95

12.09

1.5

1.3

808.84

208.37

u/ml

0.44

140

770

Alzheimer’s disease (Late onset)

251

3268

0.62

12.07

1.2

1.3

269.95

243.36

u/ml

0.25

223

2964

Glaucoma suspect

1209

9775

1.25

12.05

1.3

177.72

231.25

u/ml

2.02

1124

9028

Other noninfective disorders of lymphatic vessels and lymph nodes

166

932

1.88

12.01

1.5

1.3

179.97

219.17

u/ml

0.41

154

860

Coxarthrosis, primary

1955

13713

1.19

12.01

1.3

272.52

239.50

u/ml

0.41

1795

12757

Abnormal serum enzyme levels

905

6826

1.30

12.00

1.4

1.3

311.74

301.12

u/ml

0.06

850

6362

Cholecystitis

439

3079

1.45

11.99

1.5

1.3

233.52

232.39

u/ml

0.01

407

2825

Type 2 diabetes, wide definition

3024

16619

1.16

11.98

1.4

1.3

267.27

226.78

u/ml

1.07

2820

15523

Exclusions for E4_PCOS_CONSORTIUM

3474

19094

1.15

11.96

1.4

1.3

206.70

209.56

u/ml

0.03

3234

17816

Seronegative rheumatoid arthritis

403

2791

1.48

11.89

1.4

1.3

141.45

211.82

u/ml

2.11

374

2582

Pneumococcal septicemia

148

805

1.94

11.87

1.7

1.3

186.27

250.98

u/ml

0.45

135

745

Giant cell arteritis

145

781

1.94

11.84

1.4

1.2

184.01

213.94

u/ml

0.22

134

713

Postmenopausal osteoporosis with pathological fracture

209

1251

1.73

11.84

1.6

1.3

194.67

171.81

u/ml

0.18

187

1140

Oral lichen planus, including avohilmo , including avohilmo

303

1993

1.58

11.79

1.3

95.88

187.53

u/ml

4.68

283

1849

Unspecified kidney failure

295

1918

1.57

11.74

1.3

342.11

257.34

u/ml

0.36

270

1767

Intestinal malabsorption

209

1261

1.74

11.71

1.6

1.3

324.13

201.19

u/ml

0.39

192

1177

Other and unspecified injuries of ankle and foot

216

1317

1.72

11.66

1.4

1.3

161.04

215.77

u/ml

1.04

210

1217

Type 2 diabetes

4280

22100

1.13

11.66

1.4

1.3

250.12

221.27

u/ml

0.90

3981

20677

Benign lipomatous neoplasm

1070

8584

1.27

11.62

1.3

169.87

238.45

u/ml

3.32

1002

7971

Unspecified urinary incontinence

331

2219

1.54

11.62

1.4

1.3

181.46

216.09

u/ml

0.30

302

2048

Type 2 diabetes, definitions combined, including avohilmo

4092

21055

1.13

11.59

1.4

1.3

244.96

224.73

u/ml

0.57

3816

19697

Urolithiasis

1043

8338

1.27

11.58

1.4

1.3

253.76

273.27

u/ml

0.21

980

7770

Residual foreign body in soft tissue

207

1246

1.73

11.57

1.4

1.3

200.06

236.46

u/ml

0.35

199

1149

Ménière disease

331

2221

1.53

11.56

1.3

219.52

203.29

u/ml

0.09

316

2042

Other superficial mycoses

125

652

2.05

11.54

1.5

1.3

178.64

206.97

u/ml

0.24

118

607

Systemic sclerosis (FG)

113

568

2.13

11.52

1.3

1.2

71.39

240.60

u/ml

2.62

106

524

Oligomenorrhoea

184

1082

1.79

11.42

1.4

1.3

679.44

299.50

u/ml

0.31

170

1002

Acne vulgaris

446

3178

1.45

11.42

1.3

264.35

278.98

u/ml

0.12

418

2954

Event of undetermined intent

290

1904

1.58

11.38

1.5

1.3

236.16

257.56

u/ml

0.12

275

1768

Eustachian salpingitis and obstruction

387

2695

1.49

11.37

1.4

1.3

258.75

251.22

u/ml

0.03

369

2530

Additional codes for the location of defect, injury or illness

248

1573

1.64

11.34

1.4

1.3

274.01

263.65

u/ml

0.04

234

1469

Cerebral cysts

254

1622

1.63

11.28

1.4

1.3

329.55

258.48

u/ml

0.24

232

1512

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

4.55

11.25

1.4

72.86

322.43

u/ml

0.80

Phobic anxiety disorders

640

4831

1.35

11.19

1.4

1.3

181.00

228.00

u/ml

1.00

587

4514

Use of memantine

336

3952

0.68

11.02

1.2

1.3

291.51

262.54

u/ml

0.29

303

3596

Use of other anti-dementia drugs

336

3952

0.68

11.02

1.2

1.3

291.51

262.54

u/ml

0.29

303

3596

Hypoplasia of dental enamel

407

2.49

11.00

2.1

1.4

162.31

327.34

u/ml

1.17

391

SLE, ICD10

167

968

1.83

11.00

1.3

130.51

193.00

u/ml

0.79

151

892

SLE, strict definition

167

968

1.83

11.00

1.3

130.51

193.00

u/ml

0.79

151

892

Injuries to the hip and thigh

1692

12772

1.20

11.00

1.4

1.3

232.03

250.98

u/ml

0.33

1564

11844

Degeneration of macula and posterior pole

1403

8945

1.22

10.93

1.3

224.31

243.47

u/ml

0.29

1292

8239

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1017

8190

1.27

10.90

1.3

259.99

225.92

u/ml

0.36

931

7663

Injuries to the elbow and forearm

3118

23569

1.14

10.90

1.4

1.3

237.47

242.54

u/ml

0.10

2898

21945

Lichen sclerosus et atrophicus

446

3204

1.43

10.88

1.4

1.3

188.86

178.77

u/ml

0.11

417

2973

Tongue abnormality

239

1519

1.63

10.83

1.5

1.3

149.83

201.62

u/ml

0.78

228

1401

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

699

5213

1.33

10.82

1.3

192.58

270.20

u/ml

1.85

666

4865

Transient ischemic attack

1632

10909

1.20

10.82

1.4

1.3

215.27

254.33

u/ml

1.10

1501

10116

Fracture of lumbar spine and pelvis

698

5341

1.32

10.82

1.4

1.3

276.81

248.01

u/ml

0.24

653

4922

Recurrent dislocation and subluxation of joint

293

1947

1.55

10.81

1.4

1.3

204.02

268.35

u/ml

0.68

270

1820

Other acute skin changes due to ultraviolet radiation

140

771

1.91

10.79

1.5

1.2

574.93

187.29

u/ml

1.50

132

713

Familial hypercholesterolemia

427

3039

1.43

10.79

1.3

213.19

274.13

u/ml

0.91

399

2796

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

317

4633

0.67

10.76

1.3

286.35

240.71

u/ml

0.40

291

4291

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

736

5544

1.32

10.69

1.3

192.48

265.53

u/ml

1.81

701

5172

Unspecified haematuria

1326

8902

1.23

10.67

1.4

1.3

278.12

285.51

u/ml

0.06

1242

8293

Periapical abscess

1899

16229

1.18

10.66

1.3

353.36

239.93

u/ml

1.25

1762

15178

Epilepsy

1042

8382

1.25

10.65

1.4

1.3

180.34

269.66

u/ml

2.79

945

7791

Exposure to other and unspecified inanimate mechanical forces

329

2249

1.51

10.62

1.5

1.3

282.63

269.28

u/ml

0.07

306

2096

Thyrotoxicosis

1014

8178

1.26

10.62

1.4

1.3

168.06

217.63

u/ml

1.43

953

7583

Other disorders of binocular vision

366

2.40

10.61

1.5

1.3

114.41

225.19

u/ml

1.31

342

Injury of muscle and tendon at hip and thigh level

416

2968

1.44

10.60

1.4

1.3

176.33

226.43

u/ml

1.04

390

2767

Substance abuse, excluding more controls

2159

15535

1.17

10.60

1.4

1.3

453.67

237.21

u/ml

5.33

2006

14579

Superficial injury of forearm

447

3231

1.42

10.57

1.4

1.3

190.82

253.54

u/ml

0.89

415

3002

Vitamin deficiency

197

1203

1.70

10.51

1.4

1.3

337.13

200.56

u/ml

0.47

183

1114

Vitamin deficiency, wide

197

1203

1.70

10.51

1.4

1.3

337.13

200.56

u/ml

0.47

183

1114

Other ulcerative colitis

253

1643

1.60

10.49

1.5

1.3

196.83

209.38

u/ml

0.09

237

1538

Acute tubulo-interstitial nephritis

2512

18486

1.16

10.42

1.4

1.3

228.04

231.89

u/ml

0.07

2324

17193

Special screening examination for neoplasms

200

1223

1.68

10.40

1.4

1.3

188.45

268.37

u/ml

0.74

187

1116

Astigmatism

296

1990

1.54

10.39

1.4

1.3

182.88

291.01

u/ml

0.99

273

1847

Abnormal findings on diagnostic imaging of central nervous system

215

1348

1.66

10.36

1.3

193.25

210.25

u/ml

0.13

197

1254

Disorders of mineral metabolism

316

2150

1.51

10.36

1.4

1.3

245.65

228.13

u/ml

0.07

296

1991

Other infective otitis externa

250

1623

1.60

10.35

1.5

1.3

463.00

200.56

u/ml

0.70

234

1513

Other congenital malformations of skin, including avohilmo

372

2621

1.47

10.31

1.5

1.3

164.61

228.28

u/ml

0.90

344

2446

Sequelae of injuries of upper limb

390

2768

1.45

10.26

1.4

1.3

162.67

213.48

u/ml

1.21

365

2588

171

1003

1.74

10.25

1.3

137.58

218.29

u/ml

1.73

158

928

Acute pancreatitis

630

4807

1.33

10.24

1.4

1.3

278.24

263.05

u/ml

0.14

587

4459

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgE [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS